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General introduction
8 Chapter 1
During anesthesia the depth of hypnosis is mostly evaluated by the skill and knowledge 
of the anesthesiologist. Clinical tools developed to assess the depth of hypnosis are 
generally cumbersome to use during a surgical procedure and are less reliable in 
patients receiving neuromuscular-blocking agents. Accidental awareness during general 
anesthesia in children has been reported to be 0.2% to 1.2% [1]. About 50% develops 
long-term psychological effects, while some develop PTSD further in their life with 
varying degree of disabilities [1]. 
There is also potential harm in giving too deep (i.e. too much) anesthesia, as it can result 
in hemodynamically instability or respiratory adverse effects (e.g. bronchospasm with 
desflurane). Concerns have been raised about possible neurotoxicity of anesthetics in the 
developing brain of children [2]. Animal model studies observed behavioral changes and 
increased neuro-apoptosis when administering anesthetics for a prolonged period [3]. 
These effects of anesthetics also seem to be more prominent with increasing doses [4].
It is unknown how to interpret and extrapolate these results in humans. A large 
international randomized controlled trial revealed that sevoflurane anesthesia for a short 
duration (less than 1 hour) did not impair the cognitive function of children at the age of 
2 and 5 years old [5,6]. 
Whether these results can be generalized to longer durations of anesthesia or a mixture 
of anesthetics remain unknown. However, studies comparing hypnosis monitor guided 
anesthesia with conventional anesthesia demonstrate a reduction in cumulative anesthetic 
dose administered in adults and children [7-9]. Therefore, if the anesthetic depth can be 
reliably assessed and monitored, the exposure to potential harmful anesthetics can be 
reduced to a minimum level while maintaining an appropriate depth.
The discovery of the relationship between EEG patterns and the depth of hypnosis 
evolved the method used to monitor it. The B-Aware trial demonstrated a reduction of 
82% in accidental awareness in the adult population [10], indicating that using a depth 
of hypnosis monitor might also improve the quality of anesthesia for children. Different 
commercially available devices exist to continuously monitor the depth of hypnosis. 
Most of these devices analyze the spontaneous EEG and calculate by algorithm an index 
value representing the depth of hypnosis. Along the EEG, mid-latency auditory evoked 
potentials (MLAEP) are also possible to be used to generate an index value. However, 
great heterogenicity exists in how to interpret and respond to these generated index 
values (EEG derived as well as MLAEP derived). There are also controversies about the 
reliability of such a monitor for different age groups and different anesthetics. What 
do anesthesiologists think about using depth of hypnosis monitoring in children? How 
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does this relate to the current literature? What do we currently know about the MLAEP in 
children during general anesthesia? How does a MLAEP based hypnosis monitor perform 
in children during anesthesia with commonly used anesthetics in our daily practice?
Commonly used EEG monitors analyze the whole EEG while filtering the noise. While 
these monitors are also widely used in the pediatric population, one cannot deny the 
differences between the EEG of an adult and one of a child as the EEG does not mature 
before adulthood [11]. The MLAEP on the other hand, which is a part of an EEG, mature 
earlier in life. Just like the EEG, an index value can be derived by analyzing the MLAEP 
waveform. It is induced by a sound stimulus and appears at about 40ms until 50ms after 
it. The waveform usually consists of two peaks (P) and three troughs (N) being named 
N0, P0, Na, Pa and Nb. Its relationship with the depth of hypnosis has been studied in 
children revealing a reasonable correlation [12-15]. These studies show that an increasing 
dose of anesthetics results in an increased time until specific waveforms appear, i.e. the 
latency, and a decreased amplitude of the waveforms [16-18]. In children however, few 
studies concerning the performance of such a monitor during anesthesia are available 
of which most of them are conducted with legacy devices or experimental setups not 
readily available to the anesthesiologist for daily practice. 
Finally, we will assess the performance of the currently only commercially available 
MLAEP based monitor, the aepEX plus monitoring system, in children during propofol, 
sevoflurane and desflurane anesthesia. Studies concerning the aepEX monitor in the 
adult population demonstrated a reasonable detection of return of consciousness after 
anesthesia with propofol and sevoflurane [19-22], while the same studies in children were 
lacking. It is also unknown whether the results from the studies conducted in the adult 
population and previously conducted studies in children with other MLAEP monitors 
could be extrapolated to the aepEX monitor. This is especially true due to the fact that 
algorithms of these devices are undisclosed to the public.
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AIMS OF THIS THESIS
■■ To assess the thoughts and opinions of (pediatric) anesthesiologists about the use of 
depth of hypnosis monitoring in children receiving anesthesia.
■■ To inventory the perceived need for a reliable depth of hypnosis monitor for children.
■■ To review the current literature concerning the use of MLAEP in children receiving 
anesthesia.
■■ To evaluate the performance of the aepEX monitor (since this is currently the only 
commercially available MLAEP based hypnosis monitor) in children receiving 
anesthesia with commonly available hypnotics.
OUTLINE OF THIS THESIS
Chapter 2 will set out the thoughts, practice, opinions and (mis)understandings towards 
depth of hypnosis monitoring during anesthesia in children. An attempt to answer 
research questions concerning the use of depth of hypnosis monitoring such as: “Why 
do they use it?”, “Why don’t they use it?”, “When do they use it?”, “Are there any particular 
paradigms obstructing an informed decision for its use?”. We will also try to gauge the 
opinions about the shortcomings of the currently available depth of hypnosis monitors 
and what an ideal monitor should be capable of which might give direction for further 
development in this field.
MLAEP has a theoretically advantage over EEG based depth of hypnosis monitors. In 
chapter 3 we will review the current literature concerning MLAEP in children during 
anesthesia, addressing the following research questions: “Does the MLAEP consistently 
change when different anesthetics are administered?”, “How reliable can you assess the 
depth of hypnosis with an MLAEP based monitor?” and “Does MLAEP guided anesthesia 
make our anesthesia more efficient, i.e. do we need less anesthetics, can we reduce the 
recovery time?”.
In the following chapters the aepEX plus monitoring system will be evaluated for its 
performance as a depth of hypnosis monitor in children. Chapter 4 will describe its 
performance during propofol anesthesia, guided by the Paedfusor target controlled 
infusion model. In chapter 5 the aepEX monitor will be assessed during sevoflurane 
anesthesia. The aepEX monitor is evaluated during desflurane anesthesia in chapter 6. 
In chapter 7 we will discuss the main findings and conclusions from this thesis. 
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ABSTRACT
BACKGROUND: To assess the thoughts of practicing anaesthesiologists about the use of 
depth of hypnosis monitors in children. 
METHODS: Members of the European Society for Paediatric Anaesthesiology were invited 
to participate in an online survey about their thoughts regarding the use, applicability 
and reliability of hypnosis monitoring in children.
 
RESULTS: The survey achieved a response rate of 30% (n=168). A total of 138 completed 
surveys were included for further analysis. Sixty-eight respondents used hypnosis 
monitoring in children (Users) and 70 did not (Non-users). Sixty-five percent of the 
Users reported prevention of intra-operative awareness as their main reason to apply 
hypnosis monitoring. Among the Non-users, the most frequently given reason (43%) 
not to use hypnosis monitoring in children was the perceived lack or reliability of the 
devices in children. Hypnosis monitoring is used with a higher frequency during propofol 
anaesthesia than during inhalation anaesthesia. Hypnosis monitoring is furthermore 
used more frequently in children >4 years than in younger children. An ideal hypnosis 
monitor should be reliable for all age groups and any (combination of ) anaesthetic drug. 
We found no agreement in the interpretation of monitor index values and subsequent 
anaesthetic interventions following from it.
CONCLUSIONS: Prevention of intraoperative awareness appears to be the most important 
reason to use hypnosis monitoring in children. The perceived lack of reliability of hypnosis 
monitoring in children is the most important reasons not to use it. No consensus currently 
exists on how to adjust anaesthesia according to hypnosis monitor index values in 
children.
Keywords: Child; Consciousness Monitors; Infant; Surveys and Questionnaires.
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BACKGROUND
With the introduction of processed electroencephalography, about 20 years ago, the 
electroencephalogram (EEG) became feasible to be used to easily monitor depth of 
hypnosis (DoH) in patients receiving general anaesthesia [1]. Whether or not DoH-
monitors (DoH-M) have a beneficial impact on peri-operative outcomes, remains subject 
to discussion [2]. What all currently commercially available DoH-M have in common is that 
they have been developed for use in adult patients. Clear recommendations regarding 
the use of the currently available DoH-monitors in paediatric patients are still lacking [3].
The Paediatric Anaesthesia Research Group at Sophia Children’s Hospital in Rotterdam 
designed and launched an online survey [4] to assess the thoughts of the members of the 
European Society for Paediatric Anaesthesiology (ESPA) regarding the use, applicability 
and reliability of DoH-monitoring in children. Besides general aspects regarding the use 
of DoH-M in children, we were also interested in the thoughts of ESPA members regarding 
the requirements of an ideal paediatric DoH-M and whether demographic characteristics 
of the anaesthesiologist (age, working experience, etc.) influenced their vision regarding 
DoH-monitoring in children.
METHODS
According to the Dutch regulations, questionnaire research does not fall under the 
scope of the Medical Research Involving Human Subjects Act (WMO), as declared by 
the Central Committee on Research Involving Human Subjects (http://www.ccmo.nl/
en/questionnaire-research). Therefore, formal ethics approval was deemed unnecessary 
according to national regulations and was not obtained.
During the development of the survey, it was evaluated and tested by anaesthesiologists 
of our paediatric anaesthesia department. The survey consisted of two major parts, 
beginning with questions concerning the respondents’ demographics, workplace, annual 
personal case-loads and availability of DoH-M at their institutions. The second part was 
related to the thoughts of the respondents regarding their personal practice of DoH-
monitoring in children and their thoughts about paediatric DoH-monitoring in general. 
In order to minimize possible bias, the order of the answers to any of our multiple-
choice questions were randomized for each respondent. The entire survey is available as 
supplementary content (see appendix).
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On our request, ESPA invited their members (n=553) by email to participate in our survey. 
A single reminder was send by e-mail three weeks after the initial invitation. The survey 
was accessible online in the period from June 28, 2013 until August 18, 2013.
Statistical Analysis
Respondents were allocated to two groups; “Users” and “Non-users” of DoH-M in children. 
Non-users were excluded from further analysis when their only reason to not use DoH-M 
in children was due to the unavailability of a DoH-M in their institution since this was 
considered a circumstantial reason rather than a personal choice. For nominal data 
Pearson’s Chi-Square or Fisher’s test were used to analyse the differences between DoH-M 
Users and Non-users. When needed, data was recoded to maintain a minimum expected 
count of 5 to facilitate the Pearson’s Chi-Square or, if applicable, the Fisher’s Exact test. The 
Mantel-Haenszel test [5], labelled as a ”Linear-by-Linear Association” in SPSS, was used for 
ordinal data (e.g. work experience, age or frequency of giving anaesthesia to certain age 
groups). P-values <0.05 were considered statistically significant. 
The margin of error for our survey data, including a 95% confidence level was computed 
using an online-tool provided by SurveyMonkey [4]. The margin of error is an estimate 
of the appropriateness of the sample size to represent the whole population (ESPA 
members).
All analyses were performed using SPSS (IBM SPSS Statistics, version 21).
RESULTS
We received a total of 168 (30%) responses, of which 14 were incomplete and excluded 
from analysis. Sixteen respondents didn’t use DoH-M in children due to the unavailability 
of any DoH-M in their institution and were excluded from further analyses. The margin of 
error of our sample size was 6%.
Our respondents came from 40 different countries. To present the data in a more 
comprehensible manner, we categorized them into continents. The majority (n=115; 83%) 
came from Europe. Baseline characteristics, i.e. professional title, age, type of institution 
they work in, years of experience in anaesthesiology, of the Users (n=68) and Non-users 
(n=70) are summarized in Table 1.
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Table 1. Respondents’ baseline characteristics.
Users (n=68) Non-users (n=70) P-value
Professional title 0.366*
Anaesthesiologist 67 (99%) 66 (94%)
Anaesthesiologist in training 
(resident)
1 (1%) 4 (6%)
Practicing in n/a
Europe 57 (84%) 58 (83%)
Middle East 6 (9%) 4 (6%)
East Asia 1 (1%) 2 (3%)
Australia 1 (1%) 3 (4%)
South Americas 2 (3%) 1 (1%)
North Americas 1 (1%) 2 (3%)
Works in 0.064a
(university) children hospital 41 (60%) 31 (44%)
non-children’s hospital 27 (40%) 39 (56%)
Years of practice 0.898b
<10 years 17 (25%) 20 (29%)
11–20 years 27 (40%) 24 (34%)
>20 years 24 (35%) 26 (37%)
Age 0.908b
<40 years 20 (29%) 20 (29%)
41–50 years 25 (37%) 28 (40%)
>51 years 23 (34%) 22 (31%)
Comparison of baseline characteristics of respondents either using (Users) or not using (Non-users) depth 
of hypnosis monitoring in children.
a Fisher’s Exact test
b Mantel-Haenszel test
The workplace distribution was 60% children’s hospital and 40% general hospital among 
DoH-M Users. For the Non-users the distribution was 44% children’s hospital and 56% 
general hospital. Though not reaching statistical significance (Fisher’s exact test, p= 0.064), 
these results indicate a weak evidence that anaesthesiologists working in children’s 
hospitals are more likely to use DoH-M than those working in general hospitals.
Both Users (94%) and Non-users (86%) were “most” familiar with the Bispectral Index 
(BIS) monitor (p=0.09), followed by Entropy (Users 37%, Non-users 26%; p=0.11), the 
Narcotrend (Users 18%, Non-users 17%; p=0.56) and the AEP-monitor/2 (Users 13%, Non-
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users 10%; p=0.37). The BIS monitor was used most frequently (77%), followed by Entropy 
(10%), Narcotrend (6%) and the Cerebral State Index, CSI (4%).
In order of descending frequency, DoH-M was used during major surgery (96%), 
neurosurgery (53%), minor surgery (32%), cardiac surgery (22%) and procedural sedation 
(19%). 
A total of 70 respondents reported to never use DoH-M in children. The majority of 
them (49%) reported that they think DoH-M was unreliable and/or not validated for 
use in children. Other reasons were that using a DoH-M wouldn’t affect their method of 
anaesthesia (30%) and the cost of using DoH-M (24%). 
Prevention of intraoperative awareness was the most frequently reported primary reason 
to apply DoH-M, whereas preventing (possible) side effects of anaesthetic agents were 
most frequently reported as least relevant (for details see Figure 1).
Ranked 2nd
38%
22%
22%
18%
To enable use of
less anaesthetic
agents
Prevention of (possible)
side effects of
anaesthetic agents
Decrease time
to awakening
Prevention of
intra-operative
awareness
Ranked 3rd
40%
25%
23%
12%
Ranked 4th
44%
35%
15%
6%
Ranked 1st
65%
22%
10%
3%
Figure 1. Reasons for hypnosis monitoring. Percentage Users reported their reasons to use depth of 
hypnosis monitoring in children ranked 1st, 2nd, 3rd and 4th.
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The frequency of using DoH-M ranged from 25% in pre-term infants to 98% in teenagers. 
About 10% of the Users reported to apply DoH-M almost always in patients older than 4 
years. Details are given in Figure 2.
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Figure 2. Hypnosis monitoring and age. Patient population in which depth of hypnosis monitoring is being 
used.
All Users reported to use DoH-M during propofol anaesthesia. DoH-M was less frequently 
used during inhalation anaesthesia (see Figure 3).
Being asked whether either the actual value of a DoH-Index or its trend over time best 
reflect the DoH, 62% of the Users preferred to rely on a combination of the actual index 
value and its trend. Such a combination would result in various drug interventions, such 
as increasing the hypnotic agent concentration (27%), analgesic agent application (3%), 
or both (60%), while 10% would not react without additional changes in physiological 
parameters, i.e. heart rate or blood pressure. Twenty-nine percent of the Users found the 
DoH best represented by the trend. In the case of an increasing trend they would increase 
the hypnotic drug concentration (35%), or give additional analgesic drugs (4%) or both 
(46%), while 13% would only react to the increasing trend when combined with changes 
in physiological parameters. Another 7% relied only on increases of the actual DoH-index 
value, resulting in increasing hypnotic drug concentration (24%), additional analgesic 
drug application (3%) or both (41%), with 31% of them also requiring physiological 
alterations for an intervention (1% answered “other”). 
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Figure 3. Hypnosis monitoring and anaesthetic. Percentage respondents who “never”, “sometimes”, 
“regularly” or “always” use depth of hypnosis monitoring with different anaesthetics.
According to all respondents, applicability in all patient age groups, reliability for any 
(combination of ) anaesthetic drug, and low-cost disposables were the three most 
important requirements of a theoretical ideal DoH-M. For more details see Figure 4.
Eighty percent of the respondents (n=110) agreed that there is a need for a monitor which 
specifically measures analgesia. Fourteen of the respondents (10%) agreed to the need for 
a separate analgesia monitor, 43 (31%) preferred a combined analgesia/DoH-M monitor 
and 53 (38%) agreed to both options. Another fourteen (10%) respondents held a neutral 
position (“not knowing”) and 14 (10%) disagreed with both types of analgesia monitors. 
With respect to their thoughts about the need for analgesia monitoring devices, a Mantel-
Haenszel test revealed that Users are more optimistic towards it (p=0.04), while no 
evidence of a difference between DoH-M Users and Non-users regarding their thoughts 
about a stand-alone analgesia monitor (p=0.63) or a combined DoH/analgesia-monitor 
(p=0.12) was observed.
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Figure 4. The ideal hypnosis monitor. Features of an ideal depth of hypnosis monitor ranked 1st, 2nd, 3rd, 4th, 
5th and 6th by percentage Users and Non-users.
DISCUSSION
Practicing anaesthesiologists dedicated to paediatric anaesthesia perceive the avoidance 
of intraoperative awareness as the most important reason to use DoH-M in children. The 
most cited reasons of not using DoH-M in children were serious concerns regarding the 
reliability of the currently available devices in paediatric patients.
This survey gives an overview of the thoughts and attitudes of (European) anaesthesio-
logists affiliated with the ESPA concerning the use of DoH-M in children. 
Not unexpectedly, the BIS monitor was the device most widely available, regardless of 
the personal preference to use it or not. Working experience (Table 1) and familiarity with 
DoH-M were not related to its use in children.
As expected, DoH-M was most often applied in older children, whereas its use in 
(preterm) neonates was infrequent (see Figure 2). This pattern is in accordance with a 
recommendation made by Davidson [3], who reported increasing evidence that DoH-M 
devices do not work in infants, while there is also increasing evidence they may work in 
older children.
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Interestingly, despite the absence of scientific publications investigating the effect 
of DoH-M on the incidence of intraoperative awareness in children, this remains the 
most common indication reported by DoH-M Users to apply this technology. What we 
currently know, is that the incidence of awareness in children (approximately 1% [6]) is 
significantly higher than in adults (approximately 0.1–0.2 % [7]). In addition, the big trials 
performed in adult patients investigating the impact of BIS monitoring on the incidence 
of awareness showed conflicting results, reporting both a reduction of awareness cases 
[7] and no beneficial effect [8]. Use of less anaesthetics and decreased time to awakening, 
both reported in paediatric studies [9-12], were ranked 2nd and 3rd in the decision finding 
process to use DoH-M. At least 44% of the Users chose “prevention of (possible) side effect 
of anaesthetic agents” as the least important argument for using DoH-M. Bearing in mind 
the ongoing discussion about the safety and possible neurotoxicity of anaesthetic drugs 
in the developing brain [13-15], we regard this as an unexpected finding. 
Not surprisingly, 39% of the Non-Users chose “Applicability in all age groups” as their 
most important feature of a hypothetical ideal DoH-M. Users on the other hand chose 
“prevention of intra-operative awareness” and “To enable use of less anaesthetic agents” 
as their main reason to use DoH-M in children. These opinions were also reflected by their 
preferences regarding the most important features of an ideal DoH-M, i.e. “Applicability in 
all age groups” and “Reliability for any (combination of ) anaesthetic drug”.
Index values are helpful and practical to make the EEG understandable during anaesthesia. 
However, subtle EEG-information will be lost. With no doubt, a raw EEG display on a DoH-M 
could contribute to assessing the DoH, under the prerequisite that the anaesthesiologist 
has at least some basic knowledge of clinical encephalography [16]. The latter applies 
only to a minority of clinical anaesthesiologists. Therefore, it is not at all surprising that 
this feature was ranked only 5th by most of the respondents.
All Users applied DoH-monitoring, with frequencies varying from “sometimes” to “always” 
during propofol anaesthesia. This is in accordance with recent UK guidelines published 
by the National Institute for Health and Care Excellence (NICE), recommending the use of 
DoH monitoring in all patients receiving total intravenous anaesthesia [17]. DoH-M was 
used much less frequently during inhalation anaesthesia. This could be due to the fact 
that it is nowadays well known that end-tidal concentrations of inhalation anaesthetics 
are closely linked to the likelihood of being awake. For paediatric patients the minimal 
alveolar concentration of sevoflurane associated with wakefulness (MACawake) has been 
found to be as low as 0.2–0.3% [18].
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The survey also showed disparities in how to interpret the index values and how to 
intervene. While the device manufacturers typically advise to keep the values of their DoH-
Index within a predefined range, the majority of our respondents (62%) believed that the 
combination of the actual index value and its trend best indicates DoH. In a recent study, 
performed in adult patients, Schneider et al. [19] demonstrated that combining the BIS 
with standard anaesthesia parameters (i.e. heart rate) resulted in a prediction probability 
[20] value of 1.0 to detect consciousness. This suggests that this combination is the perfect 
indicator of DoH; at least when assuming DoH equals losing and regaining consciousness. 
Being asked how to react on increasing DoH-index values, our respondents’ answers 
showed a huge variability, ranging from increasing the hypnotic drug concentration, 
giving additional analgesic drugs, increasing both hypnotics and analgesics or even 
deciding not (yet) to intervene at all. An analgesia monitor could assist in deciding which 
intervention is probably needed and most respondents agreed with the need for an 
analgesia monitor. 
Since the majority of the ESPA members did not voice their opinions (30% response rate), 
we have to bear in mind that the results of this survey could be biased. On the other hand, 
the relatively low margin of error indicates that our sample size represents 95% of the all 
ESPA members with a ±6% margin. The low response rate can be regarded as a result in 
its own right. This could be interpreted as if the majority of paediatric anaesthesiologists 
have either significant reservations regarding the reliability and/or applicability of 
DoH-M in children or, more generally a low level of interest in this subject. We cannot 
claim to present data which is representative for the European paediatric anaesthesiology 
community. Nonetheless, we still consider our results relevant, because they very well 
reflect the tenor of the usual informal inter-collegial conversation regarding paediatric 
DoH-M during conferences or daily practice.
There is at least a theoretical possibility that respondents who did not have DoH-M 
available at their institutions would have favoured use of these devices, if given the 
choice. The design of our survey did not take into account this possibility, which could 
be regarded as a shortcoming. On the other hand, it would not be correct to assign these 
respondents to the Non-user group, which consisted by default of respondents who had 
DoH-M available but decided not to use them in children.
As long time users of various DoH-monitoring devices in children we would like to 
share our vision on this controversial topic with our readers and provide the following 
recommendations: In accordance with the current UK NICE guidelines [17] we highly 
recommend the use of DoH-monitoring during propofol anaesthesia in all paediatric 
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patients beyond infant age [3]. In children receiving inhalational anaesthesia we 
recommend the use of DoH-monitoring devices which provide the anaesthesiologist 
with additional information regarding the raw-EEG. This information is vital to prevent 
the child, in particular of the youngest age group, from EEG burst suppression patterns, 
indicating anaesthetic drug overdose.
Future research in this field should focus on the youngest patient age group. A very 
promising recent approach is the interpretation of the EEG power spectrum, displayed 
as Density Spectral Array (DSA). The major advantage of DSA is that it uses raw-EEG 
information in real time and that drug specific EEG-signatures have been identified [21], 
even for paediatric patients [16,22]. This new technology is already implemented in several 
commercially available DoH-monitors.
CONCLUSIONS
In conclusion, for ESPA affiliated anaesthesiologists who filled in our survey, prevention of 
intraoperative awareness was the most important reason to use DoH-M in children. The 
perceived lack of reliability of the currently available devices, when used in children, was 
the most important reason for not using DoH-M. No consensus currently exists on how to 
adjust anaesthesia according to DoH-M indices in children. According to the respondents 
to this survey an ideal DoH-M should be reliable for all age groups and any (combination 
of ) anaesthetic agent. 
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APPENDIX
The survey as presented to our respondents.
Dear colleague, 
 
Thank you very much for agreeing to complete our survey on depth of anaesthesia 
monitoring in children.  Your input is highly appreciated. 
We estimate that it will take you approximately 7 minutes to complete the survey. 
 
Sincerely, 
 
Yuen M. Cheung 
Frank Weber 
 
Paediatric Anaesthesia Unit 
Sophia Children’s Hospital 
Erasmus University Medical Center 
Rotterdam 
The Netherlands 
 
e-mail: paediatric.anaesthesia.research@erasmusmc.nl 
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1. What is your professional title
■❍ Anaesthesiologist
■❍ Anaesthesiologist in training (resident)
■❍ Nurse Anaesthetist
■❍ Physician Assistant
■❍ Other (please specify)
2. What is your age?
■❍ <30 years
■❍ 30–40 years
■❍ 41–50 years
■❍ 51–60 years
■❍ >60 years
3. In which country are you presently working?
4. In which hospital do you give your most anaesthetics?
   
5. How many years have you been practicing anaesthesiology? 
<5 5–10 11–20 >20
Years of pracatice ❍ ❍ ❍ ❍
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6. How often do you give anaesthesia for the following different patient age groups?
Never Occasionally Frequently
Pre-term neonates
Full-term neonates to 1 month
Infants 1 month to 1 year
1–3 years
4–6 years
7–12 years
13–18 years
Adult patients (>18 years)
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
7. How often do you give anaesthesia for the following types of surgery in paediatric 
patients
Never Occasionally Frequently (Almost) always
Minor surgery
Major surgery
Neurosurgery
Cardiac surgery
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
8. Which of the following depth of anaesthesia monitors are you familiar with? 
(you can choose multiple answers)
■❍ Bispectral Index
■❍ Entropy (Datex Ohmeda/ GE)
■❍ aepEX
■❍ cAAI
■❍ AEP-monitor/ 2
■❍ Cerebral State Index
■❍ Narcotrend
■❍ I don’t know any depth of anaesthesia monitor
■❍ Other (please specify)
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9. Which of the following depth of anaesthesia monitors are available at your 
institution? (you can choose multiple answers)
■❍ Bispectral Index
■❍ Entropy (Datex Ohmeda/ GE)
■❍ aepEX
■❍ cAAI
■❍ AEP-monitor/ 2
■❍ Cerebral State Index
■❍ Narcotrend
■❍ I don’t know any depth of anaesthesia monitor
■❍ Other (please specify)
10. Do you use depth of anaesthesia monitoring in pediatric patients? (respondents 
were redirected to question 12 when answered “yes”)
■❍ Yes
■❍ No
11. What is/are your reason(s) for not using depth of anaesthesia monitoring in 
paediatric patients? (you can choose multiple answers) (respondents were redirected to 
question 23 after completing this question
■❍ It’s too expensive
■❍ It’s unreliable
■❍ It doesn’t effect my method of anaesthesia
■❍ No particular reason
■❍ Other (please specify)
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12. How often do you use depth of anaesthesia monitoring in the following age 
groups?
Never Occasionally Frequently (Almost) 
always
Pre-term neonates
Full-term neonates to 1 month
Infants >1 month <1 year
1–3 years
4–6 years
7–12 years
13–18 years
Adult patients (>18 years)
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
13. For which of the following procedures do you use depth of anaesthesia 
monitoring? (you can choose multiple answers)
■❍ Minor surgery
■❍ Procedural sedation
■❍ Major surgery
■❍ Cardiac surgery
■❍ Neurosurgery
■❍ Other (please specify)
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14. Please rank the following monitors in order from those most to least frequently 
used in your personal practice (you can drag and drop the options)
Bispectral Index ❑
Not 
available
Entropy (Datex Ohmeda/GE) ❑
Not 
available
aepEX ❑
Not 
available
CAAI ❑
Not 
available
AEP-monitor/2 ❑
Not 
available
Cerebral State Index ❑
Not 
available
Narcotrend ❑
Not 
available
15. Please rank the following reasons for using depth of anaesthesia monitoring in 
order from the most to least important for you (you can drag and drop the options)
To enable use of less anaesthetich agents
Preventrion of intra-operative awareness
Decrease time to awakening
Preventrion of (possible) side effects of anaesthetic agents
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16. Do you have any other reasons for using depth of anaesthesia monitoring?
■❍ Yes
■❍ No
17. What is/are your additional reason(s), in order of decreasing importance, for 
using depth of anaesthesia monitoring in paediatric patients?
Reason 1
Reason 2
Reason 3
Reason 4
18. Which aspect of the index value do you think best indicates to the depth of 
anaesthesia?
■❍ The trend (i.e. decreasing trend or increasing trend)
■❍ The exact values
■❍ The trend and exact values (depends on the monitor)
■❍ Other (please specify)
19. How would you intervene if ONLY the trend of the index values is increasing?
■❍ Increase the hypnotics
■❍ Increase analgesics
■❍ Combination of hypnosis and analgesics
■❍  Do nothing; I only intervene when also other variables change (e.g. resp rate, 
pulse, bp etc)
■❍ Other (please specify)
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20. How would you intervene if ONLY the exact value of the index values is too high?
■❍ Increase the hypnotics
■❍ Increase analgesics
■❍ Combination of hypnosis and analgesics
■❍  Do nothing; I only intervene when also other variables change (e.g. resp rate, 
pulse, bp etc)
■❍ Other (please specify)
21. How would you intervene if the index value is increasing and too high?
■❍ Increase the hypnotics
■❍ Increase analgesics
■❍ Combination of hypnosis and analgesics
■❍  Do nothing; I only intervene when also other variables change (e.g. resp rate, 
pulse, bp etc)
■❍ Other (please specify)
22. With which of the following anaesthetic drugs do you use depth of anaesthesia 
monitoring in paediatric patients?
Never Sometimes Regularly Always Not applicalbe
propofol
sevoflurane
desflurane
isoflurane
halothane
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
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23. Do we need the following devices in paediatric anaesthesia?
Completely 
disagree
Disagree I don’t  
know
Agree Completely 
agree
Separate analgesia monitor
Combined analgesia & 
depth of hypnosis monitor
❍
❍
❍
❍
❍
❍
❍
❍
❍
❍
24. Please rank the following requirements for your ideal depth of anaesthesia 
monitor in the order from those most (1) to least (6) important. (you can drag and 
drop the options)
Applicability in all age groups
Low costs disposables
Reliability for any (combination of ) anesthetic drug
Lightweight device
Raw EEG display
Advanced artefact rejection protocol
This was our last question. We thank you for taking the time to fill in our survey.
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Evaluation of the aepEX™ monitor of 
hypnotic depth in pediatric patients 
receiving propofol-remifentanil 
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ABSTRACT
BACKGROUND: The aepEX Plus monitor (aepEX) utilizes a mid-latency auditory evoked 
potential-derived index of depth of hypnosis (DoH).
OBJECTIVE: This observational study evaluates the performance of the aepEX as a DoH 
monitor for pediatric patients receiving propofol–remifentanil anesthesia.
METHODS: aepEX and BIS values were recorded simultaneously during surgery in three 
groups of 25 children (aged 1–3, 3–6 and 6–16 years). Propofol was administered by 
target-controlled infusion. The University of Michigan Sedation Scale (UMSS) was used 
to clinically assess the DoH during emergence. Prediction probability (pk) and receiver 
operating characteristics (ROC) analyses were performed to assess the accuracy of both 
DoH monitors. Nonlinear regression analysis was used to describe the dose-response 
relationships for the aepEX, the BIS, and propofol plasma concentrations (Cp).
RESULTS: The pk for the aepEX and BIS was 0.36 and 0.21, respectively (p=0.010). 
ROC analysis showed an area under the curve of 0.77 and 0.81 for the aepEX and BIS, 
respectively (p=0.644). At half-maximal effect (EC50), Cp of 3.13 µg·ml
-1 and 3.06 µg·ml-1 
were observed for the aepEX and BIS, respectively. The r2 for the aepEX and BIS was 0.53 
and 0.82, respectively.
CONCLUSIONS: The aepEX performs comparable to the BIS in differentiating between 
consciousness and unconsciousness, while performing inferior to the BIS in terms of 
distinguishing different levels of sedation and does not correlate well with the Cp in 
children receiving propofol-remifentanil anesthesia.
Key words: Adolescent. Children, preschool. Consciousness Monitors. Evoked Potentials, 
Auditory/drug effects. Infant. Propofol
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BACKGROUND
The aepEX Plus monitoring system (Medical Device Management Ltd., Essex, UK), 
designed to monitor the depth of hypnosis (DoH) in anesthetized patients, has recently 
become available in Europe. It is currently the only commercially available monitor, 
which processes mid-latency auditory evoked potentials (MLAEP). The computer analysis 
produces an index value called aepEX, which ranges from 0 to 99. MLAEP is a promising 
physiological variable to assess the DoH [1-3]. There are, however, few published studies 
concerning the use of the aepEX Plus (aepEX) as a DoH monitor in clinical anesthesia, and 
to our knowledge, these have only been conducted in the adult population [4-7]. In this 
observational study, we investigated the performance of the aepEX as a DoH device in 
pediatric patients anesthetized with propofol and remifentanil. Simultaneously Bispectral 
Index (BIS) data were collected as a means of reference.
METHODS
After obtaining Institutional Review Board approval (ErasmusMC, Rotterdam, the 
Netherlands, MEC2011-104, NL 35976.078.11), written informed consent was obtained 
from the patient’s parents or guardians. Additionally, written assent was obtained from 
patients older than 12 years.
Seventy-five pediatric patients, scheduled for plastic, urological, orthopedic, or general 
surgery, were eligible for inclusion in the study. Patients were divided into three age 
groups of 25 patients aged 1–3, 3–6, and 6–16 years.
Patients were primarily excluded when they had clinically significant hearing impairments, 
EEG affecting conditions, taking EEG affecting drugs, needed admittance for the 
pediatric intensive care unit (PICU) and known allergies for propofol, sevoflurane and/or 
remifentanil.
After successful cannulation, a bolus of 0.5 µg·kg-1 remifentanil was given over 15 s 
followed by a continuous infusion of 0.1 µg·kg-1·min-1. Propofol was administered by a 
target-controlled infusion (TCI) pump (Alaris PK Syringe Pump, CareFusion, Houten, the 
Netherlands) programed with the Propofol Paedfusor pharmacokinetic model [8,9] and 
was initially set at a target propofol concentration (Cp) of 6.0 µg·ml
-1. 
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In case of inability to secure an i.v. access in the awake child, anesthesia induction 
was performed by mask with sevoflurane followed by i.v.-cannulation. Propofol-TCI 
and continuous remifentanil infusion were started as soon as possible. Subsequently, 
sevoflurane was stopped and washed out with high fresh-gas flow (10 l·min-1).
The airway was secured by a laryngeal mask airway. Patients were connected to a 
semiclosed anesthetic circuit (Primus®, Draeger, Lübeck, Germany) and primarily allowed 
to breath spontaneously. In case of hypoventilation, mechanical ventilation was used to 
re-establish and maintain normocapnia.
The attending anesthesiologist could apply a localregional technique suitable for the 
type of surgery. Surgery was allowed to commence at least 10 min after the application 
of a local-regional technique. If needed, additional remifentanil could be given before 
intraoperative measurements were made.
Intraoperatively, the Cp were gradually decreased from 6.0µg·ml
-1 to a minimum of 
2.0 µg·ml-1 in steps of 0.5 µg·ml-1. After each step, Cp were allowed to stabilize for at least 
1min.
If the patient showed signs of inadequate depth of anesthesia, that is, tachycardia, 
tachypnea, sweating, involuntary movements, or hypertension, during the decrease in Cp, 
the Cp and/or remifentanil could be increased.
At the end of the procedure, remifentanil and propofol administration was discontinued, 
which marked the emergence. The University of Michigan Sedation Scale (Table 1) was 
applied to assess the patient’s consciousness until a UMSS of 1 by a single researcher (Y.C.)
[10].
All patients received standard anesthesia monitoring, consisting of ECG, pulse 
oximetry, noninvasive blood pressure measurement at 5-minute intervals, temperature, 
capnography, inspired and endtidal concentrations of oxygen and, in case of inhalation 
induction, inspired and endtidal sevoflurane concentration.
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Table 1. University of Michigan Sedation Scale.
0 Awake/ Alert
1 Minimally Sedated: Tired/ sleepy, appropriate response to verbal conversation and/ or sounds.
2 Moderately Sedated: Somnolent/ sleeping, easily aroused with light tactile stimulation.
3 Deeply Sedated: Deep sleep, arousable only with significant physical stimulation.
4 Unarousable
aepEX- and BIS-monitoring
Before applying the DoH monitor sensors, the skin was swabbed with alcohol and 
abraded with Sensor Prep (Medical Device Management, Essex, UK). Attachment of the 
sensors was in accordance with the recommendations of the manufacturers. We attached 
the aepEX sensors on the left side and the BIS electrodes on the right side of the patient’s 
head. At the midline, the BIS electrode was attached above the aepEX electrode. Sensor 
placement and skin preparation were repeated until the impedance was below the 
required value as indicated by the monitors. Prior to induction of anesthesia, no baseline 
data were collected for analysis.
aepEX monitoring and data processing
To evoke MLAEP, the aepEX produces 1ms short click sounds with an intensity of 90 dB at 
a frequency of 6.9 Hz, which were delivered via a pair of headphones (MDR-V150; Sony 
Europe, London, UK). These headphones made the monitor more suitable for our pediatric 
study population than the aepEX standard silicone earphones.
The aepEX algorithm calculates the MLAEP waveform by averaging 256 cortical responses 
(sweeps) to the applied click sounds. Due to a moving time-averaging technique, the 
aepEX value is updated every 0.3 s instead of (256 sweeps / 6.9 Hz) 37s.
We used the aepEX logger software (Medical Device Management, Essex, UK, version 
1.3) to store aepEXvalues to a personal computer. Values contaminated with artifacts as 
flagged by the artifact detection routine of aepEX were excluded from further analysis.
BIS monitoring and data processing
We used a BIS Vista monitor (Aspect Systems International, de Meern, the Netherlands, 
software version 2.02) with smoothing rate set to 15s. Recordings were exported directly 
to a USB drive for subsequent offline analysis. Values having a signal quality lower than 
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50%, as reported by the BIS, were considered too heavily contaminated with artifacts and 
were discarded from further analysis.
DoH monitoring was performed throughout anesthesia until the patient regained 
consciousness. For analysis, index values of 10 s were averaged.
During emergence, index values just before every UMSS score were averaged to minimize 
interference by UMSS assessment. To prevent interobserver variability, one single 
researcher (Y.C.) collected all DoH-monitoring data and made all UMSS observations. The 
attending anesthesiologist was blinded for both monitors during the study.
Statistics
Continuous data were validated for normality by visual inspection in combination with 
the D’Agostino and Pearson omnibus normality test. Unless stated otherwise, variables 
were presented as mean (SD). Nonparametric analyses were performed with the Kruskal-
Wallis test with Dunn’s posthoc test for unpaired data, for example, differences between 
age groups, and Wilcoxon matched-pairs signed rank test for paired data, for example, 
differences between aepEX and BIS. Multiple testing of paired data was corrected with a 
posthoc Bonferroni’s correction.
Nonlinear regression calculations were used to investigate the relationship between 
index values and Cp by fitting the data in an inhibitory sigmoid Emax model:
E = E0 +
(Emax – E0)
1 + 10(logEC50–x)y
where E is the index value as shown by the DoH monitors, EC50 the Cp with half-maximal 
effect on the DoH monitors, x the Cp as indicated by the TCI pump and γ the Hillslope 
which was variable to optimize for the best fit. E0 and Emax were constrained to 0 and 
100. Only intraoperative DoH data were used for this analysis, as we could not let the Cp 
stabilize for one minute during the emergence period due to ethical reasons.
Evaluation of the predictive value of the DoH monitors for the UMSS was performed 
by calculating the prediction probability (pk) as proposed by Smith et al. [11]. A custom 
spreadsheet macro, pk MACRO, provided and described by them [11], was used for analysis. 
The pk value ranges from 0.0 to 1.0 and is calculated from index values of at least three 
different UMSS scores. A value of 0.5 means that in 50% of the cases, the DoH monitor 
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correctly predicts the clinically observed UMSS. If the device predicts the UMSS 100% 
correctly, the pk value would be 1.0. Values below 0.5 describe an inverse relationship.
To investigate the reliability of the monitors in distinguishing between consciousness 
and unconsciousness, dichotomized UMSS scores (UMSS >1 indicating unconsciousness, 
UMSS ≤1 indicating consciousness) were used to perform a paired receiver operating 
characteristic (ROC) analysis for both monitors. ROC analysis for each DoH monitor and 
age group was performed to calculate sensitivity and specificity. All ROC analyses were 
calculated using MEDCALC for Windows, version 12.3.0.0 (MedCalc Software, Mariakerke, 
Belgium). Other analyses were calculated by GRAPHPAD Prism 5 for Mac OS X, version 
5.0d (GraphPad Software, San Diego, California, USA). P-values <0.05 were considered 
statistically significant.
RESULTS
We were able to complete the registration of aepEX and BIS values until awakening in 
69 patients. In four patients (group 6–16), the Cp and/or remifentanil administration was 
increased. Data recording could not be completed due to technical or logistical difficulties 
in three, one, and two patients from groups 1–3, 3–6, and 6–16, respectively. In one patient 
(group 6–16), artifactfree aepEX values were only available during emergence. Two study 
patients (groups 1–3 and 6–16) received premedication and were excluded from further 
analysis. No patient received neuromuscular blocking agents.
For caudal blocks (n=61), ropivacaine 0.2% was administered at a dose of 1.0–1.25 ml·kg-1, 
up to a maximum of 25 ml. In two patients, a penile block was performed with bupivacaine 
0.5%, 0.2 ml·kg-1. Peripheral loco-regional techniques were applied under ultrasound 
guidance, and volumes <5 ml of ropivacaine 0.2% were injected. Demographic data of 
the patients are shown in Table 2.
Figure 1 illustrates the means of the index values of both DoH monitors during the various 
measurement points.
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Table 2. Baseline Characteristics of patients receiving propofol-remifentanil anesthesia.
1–3 years 3–6 years 3–6 years 1–18 years
(n=24) (n=25) (n=24) (n=73)
Mean age in months [IQR] 23 [14–34] 57 [43–72] 107 [74–176] 62 [14–176]
Weight in kg (mean ± SD) 12.00 ± 1.92 18.86 ± 4.01 33.19 ± 13.22 21.32 ± 11.85
Male/female 23/1 23/2 22/2 68/5
Mean duration of surgery in minutes [IQR] 87 [40-210] 87 [45-215] 87 [45-155] 87 [40-215]
Procedure
Subumbilical 21 (88%) 25 (100%) 24 (100%) 70 (96%)
Upper extremity 3 (13%) 0 (0%) 0 (0%) 3 (4%)
Locoregional technique
No block 2 (8%) 2 (8%) 2 (8%) 6 (8%)
Caudal block 21 (88%) 20 (80%) 20 (83%) 61 (84%)
Penile block 0 (0%) 1 (4%) 1 (4%) 2 (3%)
Ileoinguinal block 0 (0%) 2 (8%) 0 (0%) 2 (3%)
Axillary block 1 (4%) 0 (0%) 0 (0%) 1 (1%)
Sciatic and femoral block 0 (0%) 0 (0%) 1 (4%) 1 (1%)
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Figure 1. Mean aepEX (●■blue) and BIS (●■red) index values with 95% conﬁdence intervals at 
different propofol concentrations (Cp) and UMSS scores of all groups.
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Non-linear regression analysis revealed a median EC50 of 3.13 µg·ml
-1 (IQR: 1.94–3.96) and 
3.06 µg·ml-1 (IQR: 2.46–3.43) for the aepEX and BIS, respectively (p=0.949). Comparisons 
between different age groups within and between both monitors revealed no significant 
differences. Table 3 summarizes the results derived from the nonlinear regression analysis.
Paired comparison of pk values was possible for 26 patients. The mean pk value for the 
aepEX (PkaepEX 0.36; 95% CI: 0.28–0.45) was significantly higher than for the BIS (PkBIS 0.21; 
95% CI: 0.17– 0.25) (p=0.010).
ROC analysis for patients at the start of the emergence compared with patients assigned 
to UMSS1 revealed an area under the curve (AUC) of 0.77 (95% CI: 0.68–0.85) and 0.81 
(0.74–0.87) for the aepEX and BIS, respectively. Specificity was 2% and 16% for the aepEX 
and BIS, respectively, at 100% sensitivity. At 100% specificity, sensitivity was 14% and 15% 
for the aepEX and BIS, respectively (Figures 2 and 3).
Maximum sensitivity and specificity were, respectively, 77% and 71% for the aepEX and 
66% and 93% for the BIS at index values of, respectively, >55 and >70. The results of the 
unpaired ROC analyses are illustrated in Figures 2 and 3.
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Figure 2. The sensitivity (●■ red) and speciﬁcity (●■ blue) of the aepEX monitor to detect 
consciousness (UMSS of 1) from various index values.
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Figure 3. The sensitivity (●■red) and speciﬁcity (●■blue) of the BIS monitor to detect consciousness 
(UMSS of 1) from various index values.
DISCUSSION
This study is, to our best knowledge, the first to evaluate the applicability of the aepEX in 
pediatric surgical patients. We found that the aepEX performs comparable to the BIS in 
detecting UMSS ≤1. The aepEX was furthermore less related to Cp and performed inferior 
to the BIS in discriminating subtle differences in DoH.
Figure 1 illustrates the relationship between index values at different measurement 
moments. As opposed to the BIS, the aepEX was less affected by different Cp (see Figure 1), 
whereas at emergence from anesthesia,transition from unconsciousness to consciousness 
resulted in a significant increase in index values. This same response pattern of the 
aepEX was also reported in other studies, which were performed in adult patients [6,12]. 
Interestingly, the AEP monitor/2, which also processes MLAEP, has been reported to 
produce a comparable increase in index values at awakening [5,13-15].
The relatively constant aepEX value during maintenance and the abrupt increase at UMSS 
1 suggests that the aepEX has a weak correlation with the actual Cp, but rather with the 
clinical endpoints consciousness vs unconsciousness. This weak correlation corresponds 
with the rather low r2 (0.53) of the nonlinear regression model. The observed r2 of the 
BIS is in agreement with the current literature [16-18] and suggests a more accurate 
prediction of BIS values at different Cp. The EC50 ranging from 2.46 to 3.43µg·ml
-1 propofol 
for the BIS is comparable with published adult data (see Table 3) [17–20]. Rigouzzo et al. 
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demonstrated that the EC50 for the BIS was significantly higher in prepubertal patients 
than in postpubertal patients [16]. As we mostly had prepubertal patients, this effect, that 
is, decreasing EC50 with increasing age was not observed in our study.
Table 3. Half maximal effective concentrations derived from non-linear regression analysis of 
propofol on aepEX and BIS index values.
  1–3 years 3–6 years 6–18 years 1–16 years
aepEX
EC50* (median [IQR]) 3.24 [1.34–3.93] 2.77 [2.24–3.93] 2.97 [2.01–5.88] 3.13 [1.94–3.96]
r2 (mean ± SD) 0.49 ± 0.30 0.53 ± 0.36 0.57 ± 0.34 0.53 ± 0.33
BIS
EC50 (median [IQR]) 3.09 [2.34–3.66] 3.17 [2.94–3.61] 2.55 [2.35–3.30] 3.06 [2.46–3.43]
r2 (mean ± SD) 0.78 ± 0.22 0.87 ± 0.10 0.83 ± 0.16 0.82 ± 0.17
* EC50; Half maximal effective concentration in µg·ml
-1.
Pk analysis revealed a PkaepEX value of 0.36 indicating an inverse correlation with the UMSS, 
in other words, the aepEX predicts 64% of the UMSS correctly. The BIS had a higher 
predictive value of 79% (p=0.010).
To our best knowledge, there are currently no published studies dealing with PkaepEX 
values in pediatric patients. Two recently published studies from our own research group 
reported a pk value of 0.74 for the AEP monitor/2 calculated for 45 and 20 pediatric 
patients [13,14].
Struys et al. reported a pk value of 0.89 for the MLAEP derived A-Line Index in 20 adult 
patients receiving propofol anesthesia [21]. The differences in the observed pk values 
could, at least partially, be explained by differences in the applied study designs and the 
use of different DoH monitors.
Our own research group revealed a PkBIS of 0.74 and 0.75 in previous studies [13,14], which 
is close to our currently observed PkBIS value of 0.79.
Although pk values of only 26 patients could be calculated in this study, the PkBIS of 0.79 
seems to be in accordance with those in previously published pediatric studies; PkBIS of 
0.74 and 0.75 [13,14].
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We could not detect an age dependency for the EC50 (see Table 3) and pk values. This could 
be a type II error because we had not performed a power analysis for these parameters.
Using a precommercialized version of the aepEX, Doi et al. demonstrated that it does 
not correlate well with the Cp, whereas a sudden increase in aepEX values was observed 
when patients regained consciousness [12]. This behavior might suggest that the aepEX 
monitor does not measure a depth, but rather a clinical state (UMSS≥1). As the pk value 
describes the accuracy to predict every UMSS, this could explain the rather lower PkaepEX 
value.
In a recent editorial, Sleigh questioned the model of ‘depth of anesthesia’ in favor of a 
simple on–off switchboard mechanism theory [22]. Although solely a theory, it seems to 
match our observations of the aepEX during propofol anesthesia.
Considering the aepEX’s binary behavior, a (binary) ROC analysis could theoretically be 
more appropriate than a pk analysis. Compared with our findings, Gajraj et al. observed 
at 100% specificity, a significantly higher sensitivity for the precommercialized aepEX 
monitor (14% vs 60%) and a comparable sensitivity for the BIS (15% vs 14%) [23]. At a 
sensitivity of approximately 85%, they reported a higher specificity compared with our 
findings for the aepEX (53% vs 85%) and BIS (45% vs 80%). In a previous study by our 
own group, the BIS had a sensitivity of 12%, 85%, and 100%, respectively, at 100%, 61%, 
and 9% specificity [13]. The discrepancy found between our study and Gajraj et al., could 
be explained by the large difference in age of the study populations. ROC analyses of 
the aepEX and BIS showed no significant differences in the AUC between the three age 
groups and the groups as a whole (p=0.644).
We did not analyze the relationship between the index values and Cp during emergence, 
due to the continuous decline of Cp at that moment. The 20 s averaged index values would 
therefore not represent one Cp, but rather a range.
Our study applied the Paedfusor pharmacokinetic model to calculate the expected 
Cp based on age and weight. Cp, however, is an indirect measurement of the propofol 
concentration at the effect site, the brains. For that reason, it would have been preferable 
to assess the DoH monitors with a TCI pump programed with a pediatric effect-site 
model. Unfortunately, no such model is commercially available at this moment. Our study 
population consisted only of pediatric patients receiving propofol with remifentanil 
anesthesia and, while the effect of remifentanil on the aepEX should be minimal [24], 
extrapolations to other combinations of anesthetics with opioids for children should be 
carried out cautiously.
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Loco-regional anesthesia could have an effect on DoH. Davidson et al. demonstrated that 
a caudal block was associated with a five points decrease in BIS values compared with 
patients without a caudal block. The authors also pointed out that the clinical relevance 
of a decrease in five points is questionable [25].
In accordance with Absalom et al., who found no impact of aep monitoring on BIS values 
during propofol anesthesia, we assume that interference of aepEX- and BIS-monitoring is 
rather unlikely [26].
Having the headphones on did not give problems for UMSS assessment. The same 
headphones were used in a previously published study concerning the A-line monitor 
and UMSS, which also posed no problems in UMSS assessment [27].
We assumed that patients not known with hearing impairment would be suitable for 
aepEX monitoring. During our interaction with the patients, we did not observe any signs 
for hearing impairments and 69 patients were successfully scored with a UMSS of 1, which 
meant they had an adequate response to sound.
The investigator who collected the DoH data also made the UMSS assessments. This 
might lead to the possibility of a slight bias. We certainly would have preferred to let the 
UMSS assessments be carried out by another person. However, this was not possible for 
logistical reasons.
In conclusion, we have observed that in pediatric patients, under propofol-remifentanil 
anesthesia the aepEX performs comparably to the BIS in distinguishing consciousness 
from unconsciousness, while the aepEX is inferior to the BIS in detecting different UMSS. 
The aepEX was unaffected by age and, unlike the BIS, also Cp. The sudden increase in index 
values of the aepEX when patients regained consciousness comply with the intriguing 
hypothetic ‘switchboard-theory’ by Sleigh [22].
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ABSTRACT
BACKGROUND: The aepEX is a measure of depth of hypnosis (DoH), derived from 
processed mid-latency auditory evoked potentials.
OBJECTIVES: To evaluate the aepEX as a measure of DoH in children receiving sevoflurane–
remifentanil anesthesia.
METHODS: aepEX and bispectral index (BIS) were recorded simultaneously in 75 
children, (1–3, 3–6, and 6–18 years), receiving sevoflurane at endtidal concentrations 
(Etsevo) between 1.5 and 0.5 MAC. The Etsevo at which the aepEX and BIS had a value of 50 
(EC50aepEX and EC50BIS) was calculated by nonlinear regression analysis. The accuracy of 
aepEX and BIS to predict the DoH was assessed by prediction probability (pk) and receiver 
operating characteristics (ROC) analysis.
RESULTS: Seventy-four children were included for analysis. The EC50aepEX (2.68%) and 
EC50BIS (2.10%) were comparable; the same accounts for the EC50aepEX of the different 
age groups and the EC50aepEX and EC50BIS of corresponding age groups. The EC50BIS in 
children aged 1–3 years was lower than in the older age groups (p<0.05). Pk values of the 
aepEX (0.32, CI 95% 0.08–0.56) and BIS (0.47, CI 95% 0.19–0.75) were comparable. The 
area under the ROC curve was 0.72 (CI 95%: 0.62–0.82) and 0.67 (CI95%: 0.56– 0.77) for 
the aepEX and BIS, respectively (p=0.54). Optimal cutoff values were >60 (aepEX) and 
>68 (BIS), with corresponding specificities 91%, CI 95%: 80–97% (aepEX) and 66%, CI 95%: 
52–77% (BIS).
CONCLUSIONS: In this study with children receiving sevoflurane anesthesia, the aepEX 
outperformed the BIS in distinguishing unconsciousness from consciousness. Both 
indices performed equally bad in differentiating different levels of DoH.
Keywords: Adolescent; Child; Child, Preschool; Consciousness Monitors; Evoked Potentials, 
Auditory; Drug Effects; Infant; Sevoflurane
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BACKGROUND
Monitoring the depth of hypnosis (DoH) in pediatric surgical patients is both necessary 
and challenging. All currently available EEG-derived DoH monitors are primarily designed 
for use in adult patients. The EEG of a child has different characteristics than the adult 
EEG, the younger the child, the more pronounced the differences. Therefore, the use of 
EEG-derived DOH monitors is not recommended in children younger than two years [1].
Another approach to monitoring DoH is the analysis of mid-latency auditory evoked 
potentials (MLAEP) [2]. A potential advantage of MLAEP over the EEG in terms of their 
applicability as a measure of DoH in children is, that the differences between children and 
adults appear to be less pronounced [3].
The recently marketed aepEX Plus monitor (Medical Device Management Ltd., Essex, 
UK) processes midlatency auditory evoked potentials (MLAEPs) resulting in the so-called 
aepEX index, representing a measure of depth of hypnosis (DoH).
In this prospective observational study, we evaluated the performance of the aepEX 
monitor to detect the DoH in children of different age groups receiving sevoflurane–
remifentanil anesthesia. bispectral index (BIS) recordings were simultaneously collected 
and compared to the aepEX as a means of reference.
METHODS
After IRB approval (ErasmusMC, Rotterdam, the Netherlands, MEC 2011-104, NL 
35976.078.11) and written informed consent of the parents and patients older than 12 
years were obtained, pediatric patients aged between 1 and 18 years and scheduled for 
elective plastic, urological, orthopedic, or general surgery were eligible for inclusion in 
this study. 75 patients were stratified for age into three groups of 25 (1–3, 3–6, and 6–18 
years). Clinically significant hearing impairments, EEG affecting conditions, use of EEG 
affecting drugs (premedication included), need for admittance to the pediatric intensive 
care unit, and/or known allergies for sevoflurane and/or remifentanil served as primary 
exclusion criteria.
For induction of general anesthesia, it was first attempted to obtain and secure peripheral 
intravenous access. A slow bolus of 0.5 µg·kg-1 remifentanil was administered over 15 s 
followed by a continuous infusion of 0.1 µg·kg-1·min-1, followed by propofol (3–5 mg·kg-1) 
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or sevoflurane (without nitrous oxide) by mask. If intravenous access could not be obtained 
under awake conditions, anesthesia induction was performed by mask with sevoflurane, 
followed by i.v. access and remifentanil as described above. A laryngeal mask airway was 
used to secure the airway. Patients were connected to a semi-closed anesthetic circuit 
(Primus, Draeger, Lubeck, Germany) and primarily allowed to breathe spontaneously. In 
case of hypoventilation (endtidal CO2 >6.0 kPa), mechanical ventilation was used to re-
establish and maintain normocapnia (endtidal CO2 of 4.5–6.0 kPa).
If possible, patients received locoregional blocks for both intra- and postoperative pain 
relief. Peripheral low volume loco-regional techniques were applied under ultrasound 
guidance, using ropivacaine 0.2%. For caudal blocks, plain ropivacaine 0.2% was used at 
a volume of 1.00–1.25 ml·kg-1. For penile nerve blocks, bupivacaine 0.5% 0.2 ml·kg-1 was 
administered. If local regional techniques were not an option, remifentanil was increased 
to 0.3–0.4 µg·kg-1·min-1. Furthermore, i.v. paracetamol 15 mg·kg-1 and i.v. diclofenac 
2 mg·kg-1 were given.
Etsevo was initially adjusted to 3.9%, equivalent to 1.5 MAC values [4], in a mixture of oxygen 
and air, and subsequently decreased by steps of 0.5% at least every 5 min to a minimum 
of 1.8% to maintain an adequate DoH during the surgical procedure. A further decrease 
to 1.3% (0.5 MAC) was achieved at the start of wound closure.
Etsevo and/or remifentanil could be increased if the attending anesthesiologist had 
reason to suspect inadequate depth of anesthesia, i.e., tachycardia, tachypnea, sweating, 
involuntary movements, or hypertension.
At the end of the procedure, sevoflurane and remifentanil administration was discontinued 
and the fresh gas flow was set to 10 lmin1, which marked the start of the emergence 
period. The University of Michigan Sedation Scale [5] (UMSS, see Table 1) was used to 
assess the DoH until a score of ≤1 was reached. 
All patients received standard anesthesia monitoring consisting of ECG, pulse oxymetry, 
noninvasive blood pressure measurement, temperature, capnography, and inspired and 
endtidal concentrations of oxygen and sevoflurane.
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aepEX and BIS monitoring
The skin on the forehead was first swabbed with alcohol and abraded with Sensor Prep 
(Medical Device Management, Essex, UK). Then, the aepEX sensors were attached on the 
left side and the BIS electrodes on the right side of the patient’s head according to the 
manufacturers’ recommendations. The aepEX sensor was attached just below the BIS 
electrode at the center of the forehead.
To not distress the child unnecessarily, no baseline data of both DoH monitors were 
collected from the patients prior to the induction of anesthesia.
In patients who had an i.v.-induction with propofol, intraoperative aepEX and BIS 
measurements were postponed for 15 min after the last bolus of propofol.
Intraoperatively, values from both DoH monitors were collected at least 5 min after every 
decrease in Etsevo during the emergence period values recorded just before every UMSS 
score were used for analysis. Analyses were performed with averaged index values of 10s.
To prevent interobserver variability, one single researcher (Y.C.) collected all DoH-
monitor’s data and made the UMSS assessments. During the whole study-period, the 
attending anesthesiologist was blinded to the screens of both DoH monitors.
Table 1. University of Michigan Sedation Scale.
0 Awake/alert
1 Minimally sedated: tired/sleepy, appropriate response to verbal conversation, and/or sounds.
2 Moderately sedated: somnolent/sleeping, easily aroused with light tactile stimulation.
3 Deeply sedated: deep sleep, arousable only with significant physical stimulation.
4 Unarousable.
aepEX monitoring and data processing
The aepEX delivers click sounds with a duration of 1 ms, an intensity of 90 dB, and a 
frequency of 6.9 Hz through a pair headphones to provoke MLAEPs. As the standard 
earplugs are unsuitable for small children, we connected the aepEX to a commercially 
available over-the-ear headphone (MDR-V150; Sony Europe, London, UK).
The aepEX algorithm calculates the MLAEP waveform by averaging 256 cortical responses 
(sweeps) to the applied click sounds. The aepEX value is updated every 0.3 s by moving 
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time average technique. aepEX values were recorded to a personal computer using the 
AEPEX LOGGER software (Medical Device Management, version 1.3). Values that were 
marked by the aepEX’s artifact detection protocol were manually excluded from further 
analysis.
BIS monitoring and data processing
The BIS VISTA monitor (Aspect Systems International, de Meern, the Netherlands, software 
version 2.02) was used. The smoothing rate was set to 15 s, and BIS values were exported 
directly to a USB drive. BIS values having a signal quality of <50% were manually discarded 
from subsequent analysis.
Statistics
To investigate the relationship between DoH index values and Etsevo, the data were fitted 
in an inhibitory sigmoid Emax model:
E = E0 +
(Emax – E0)
1 + 10(logEC50–x)y
E is the index value as shown by the DoH monitors; EC50 represents the Etsevo with half-
maximal effect on the DoH monitors, x the Etsevo and γ the variable Hillslope, to optimize 
for the best fit. E0 and Emax were constrained to 0 and 100, representing the range of 
the DoH monitors. The EC50 of every individual patient was calculated separately and 
summarized according to whether the data were (non)parametric (median or mean). Only 
intraoperative DoH data were used for this analysis.
Prediction probabilities (pk) for the DoH monitors were calculated according to the method 
described by Smith et al. [6], using the custom spreadsheet macro, pk-MACRO, provided 
by the authors. The pk value describes how good a DoH index predicts the clinical DoH of 
a patient. It ranges from 0.0 to 1.0 and is calculated from index values of at least 3 different 
clinical DoH stages, in our study the UMSS. If a monitor always predicts the correct UMSS, 
the pk is 1.0. pk values below 0.5 describe an inverse relationship between the index and 
the UMSS, which is the same as 1.0 pk. A DoH monitor with a pk of 0.5 predicts only 50% 
of the clinically observed UMSS of the patient correctly, which is no better than chance.
We also performed paired and unpaired receiver operating characteristic (ROC) analyses 
and calculated the corresponding area under the curve (AUC) to evaluate the monitors’ 
performance in distinguishing between unconsciousness (UMSS >1) and consciousness 
(UMSS ≤1). The optimal combination of the sensitivity and specificity was defined as ‘max 
(Sensitivity + Specificity –1).’ ROC analyses were calculated using MEDCALC for WINDOWS, 
version 12.7.0.0 (MedCalc Software, Mariakerke, Belgium). Other analyses were calculated 
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by GRAPHPAD PRISM 5 for Mac OS X, version 5.0d (GraphPad Software, San Diego, CA, USA). 
Continuous data, for example, pk and EC50, were tested for normality by the D’Agostino 
& Pearson omnibus normality test and visual inspection. Unpaired nonparametric data 
were analyzed with the Kruskal-Wallis test combined with Dunn’s posthoc analysis, for 
example, EC50 of the different age groups. The Wilcoxon matched-pairs signed rank test 
was applied to analyze paired nonparametric data, for example, EC50 and pk of the same 
groups, and if appropriate with Bonferroni correction for multiple testing. Parametric data 
were analyzed with paired or unpaired t tests combined, in case of multiple tests with 
Bonferroni correction.
Variables were presented as mean (SD) unless otherwise stated. P-values <0.05 were 
considered statistically significant.
RESULTS
Complete datasets, suitable for subsequent analysis, could be obtained in 69 of 75 
patients. Patient characteristics are given in Table 2. One patient (group 1–3 years) received 
midazolam preoperatively and was primarily excluded from the study. An increase in 
sevoflurane during intraoperative measurements was not needed in any patient. Propofol 
was administered in three patients (group 3–6 years) during emergence due to extreme 
agitation (n=2) and laryngospasm (n=1). In one patient (group 3–6 years), conversion to 
laparoscopy after the initial operation, during which all intraoperative measurements 
were completed, required tracheal intubation. Another patient (group 6–16) pulled off the 
electrodes during emergence. As only data from the emergence period were corrupted 
and/or missing, intraoperative data from these five patients were still included for further 
analyses. 
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Figure 1. Mean aepEX (●■blue) and bispectral index (●■red) values with standard error of the 
mean at different endtidal sevoﬂurane concentrations (Etsevo) of all groups.
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Figure 2. Mean aepEX (●■blue) and bispectral index (●■red) values with standard error of the 
mean at different university of Michigan Sedation Scale scores of all groups. 
The EC50aepEX (2.68%; CI 95%: 2.24–3.86%) and the EC50BIS (2.10%; CI 95%: 1.35–3.19%) 
were not significantly different (p=0.065, after correction for multiple testing). The EC50BIS 
in the youngest patient group (1–3 years was higher) was higher than in older patients 
(p<0.05), whereas the EC50aepEX was not age dependent. For details, see Table 2 and 
Figure 1.
Due to artifact contamination of the MLAEP data during emergence, paired pk analysis 
was possible in 10 patients only. Pk values for the aepEX (PkaepEX) and BIS (PkBIS) were 
respectively 0.32 (CI 95%: 0.08–0.56) and 0.47 (CI 95%: 0.19–0.75) (p=0.23). See also 
Figure 2. The paired ROC analysis showed an AUC of 0.72 (CI 95%: 0.62–0.82) and 0.67 
(CI 95%:0.56–0.77) for the aepEX and BIS, respectively (p=0.54). At 100% sensitivity, the 
aepEX and BIS had respectively a specificity of 2% and 0%, while at 100% specificity, the 
sensitivity was respectively 31% and 21%. Maximum sensitivity and specificity for the 
aepEX were at 64% (CI 95%: 46– 79%) and 91% (CI 95%: 80–97%), respectively, at a cutoff 
index value of >60. The BIS had a maximum sensitivity and specificity of respectively 
70% (CI95%: 57– 81%) and 66% (CI 95%: 52–77%) at an index value >68. The AUC of the 
different age groups with the same monitor and AUC of same age groups with different 
monitors were not different.
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Table 2. Patient characteristics.
1–3 years 3–6 years 6–18 years 1–18 years
(n=24) (n=25) (n=25) (n=74)
Mean age in months [Range] 20 [13–29] 54 [38–66] 137 [77–188] 71 [13–188]
Weight in kg (mean ± SE) 11.3 ± 0.4 18.6 ± 0.7 43.0 ± 2.9 24.6 ± 1.9
Male/female, no 23/1 22/3 22/3 67/7
Mean duration of surgery in minutes 
[Range]
82 [32–184] 71 [15–147] 66 [20–183] 73 [15–184]
Procedures, no (%)
Subumbilical 19 (79%) 23 (92%) 24 (96%) 66 (89%)
Upper extremity 5 (21%) 1 (4%) 1 (4%) 7 (10%)
Combination of subumbilical  
and upper extremity
0 (0%) 1 (4%) 0 (0%) 1 (1%)
Locoregional technique, no (%)
Axillary block 0 (%) 0 (0%) 1 (4%) 1 (1%)
Caudal block 15 (63%) 18 (72%) 12 (48%) 45 (61%)
Epidural catheter 0 (0%) 0 (%) 1 (4%) 1 (1%)
Ileoinguinal block 0 (0%) 4 (16%) 4 (16%) 8 (11%)
Dorsal nerve of penis block 0 (0%) 1 (4%) 0 (0%) 1 (1%)
Popliteal block 0 (0%) 0 (0%) 1 (4%) 1 (1%)
Pudendal nerve block 1 (4%) 0 (0%) 0 (0%) 1 (1%)
Radial nerve block 1 (4%) 0 (0%) 0 (0%) 1 (1%)
Supraclavicular block 1 (4%) 0 (0%) 0 (0%) 1 (1%)
Infiltration by surgeon 1 (4%) 1 (4%) 1 (4%) 3 (4%)
Femoral and popliteal block 0 (0%) 0 (0%) 1 (4%) 1 (1%)
Femoral and sciatic block 0 (0%) 0 (0%) 2 (8%) 2 (3%)
Ilioinguinal and pudendal nerve 
block
1 (4%) 1 (4%) 0 (0%) 2 (3%)
No block 4 (17%) 0 (0%) 2 (8%) 6 (8%)
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DISCUSSION
In this study of children under sevoflurane–remifentanil anesthesia, the aepEX and the 
BIS perform comparably in terms of pk and AUC, whereas the aepEX outperforms the BIS 
with respect to its specificity at optimal cutoff values.
This is, to our best knowledge, the first pediatric study to examine the pharmacodynamic 
relationship between sevoflurane and the aepEX. We observed a tendency of decreasing 
EC50aepEX with age, however not statistically significant, and a significantly higher EC50BIS 
for children aged 1–3 years compared to the two older age groups (see Table 3). McCann 
et al. [7] reported an EC50BIS of 1.48% sevoflurane in oxygen/nitrous oxide mix in children 
with a mean age of 3.3 years. In terms of MAC equivalents, this is 0.74, which lies close to 
the EC50BIS of 2.10% (0.8MAC) in our study.
Table 3. Half-maximal effective concentrations derived from nonlinear regression analysis of 
sevoflurane on aepEX and BIS index values.
1–3 years 3–6 years 6–16 years 1–18 years
aepEX
EC50
a (median [IQR]) 2.29 [1.20–5.50] 2.73 [1.82–3.40] 2.11 [1.41–3.27] 2.68 [1.63–3.91]
r2 (mean ± SD) 0.34 ± 0.33 0.70 ± 0.33 0.49 ± 0.34 0.51 ± 0.36
BIS
EC50 (median [IQR]) 2.56 [2.10–3.62]* 2.04 [1.33–2.27] 1.74 [1.15–2.34] 2.10 [1.45–2.62]
r2 (mean ± SD) 0.72 ± 0.22 0.54 ± 0.31 0.70 ± 0.19 0.65 ± 0.26
aEC50; Half-maximal effective concentration in endtidal volume%.
*Significantly different from age groups 3–6 and 6–18 years (p<0.05).
It might be regarded as a shortcoming of our study that we excluded the emergence 
period from the pharmacodynamic analysis. During the emergence period, a high 
fresh gas flow of 10 l·min1 was applied to achieve a rapid washout of sevoflurane. As a 
consequence, it was technically impossible to reliably link Etsevo to the aepEX and the BIS.
Due to the high incidence of artifacts and the fact that the jackknife method for the pk 
analysis requires index values related to at least three different UMSS scores, computation 
of a pk analysis was possible in no more than 10 patients. Our observed pkaepEX of 0.32 
implies an inverse relation with the UMSS; that is, it can predict the correct UMSS in 68%. 
The BIS had an even worse prediction probability of 53%, which is just a little better than 
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pure chance. We did not observe a difference between the pkaepEX and pkBIS; however, 
the possibility of a type II error should be considered. In a study of adult patients, Kurita 
et al. [8] observed a pkaepEX (with a precommercialized version aepEX monitor) and a 
pkBIS of respectively 82% and 81%. Unfortunately, they did not report their method of 
analgesia and whether any premedication was administered, which makes it difficult to 
compare their results to ours.
In a recent study [9] we examined the performance of the aepEX in children receiving 
propofol–remifentanil anesthesia and showed a comparable specificity of 2% (vs 2% of 
the current study) for the aepEX and a higher specificity of 16% (vs 0% of the current 
study) for the BIS at 100% sensitivity. At 100% specificity, the sensitivities are 31% and 
21% for the aepEX and BIS monitor, respectively, which are higher than what we had 
previously observed with propofol (14% and 15% for the aepEX and BIS, respectively). The 
AUC of the BIS during propofol–remifentanil anesthesia was higher than observed in our 
present study (0.81 vs 0.67), while the AUC of the aepEX appears to be comparable in both 
studies (0.77 vs 0.72). The comparable AUC of the aepEX during sevoflurane and propofol 
anesthesia may imply that it is less susceptible to the different pharmacodynamics of 
these hypnotics.
Possible effects of remifentanil on the aepEX and the BIS should be considered. Schraag et 
al. [10] could show that remifentanil had no effect on MLAEPs. Guinard et al. reported the 
same for the BIS [11]. We could not find any reason why these findings should not account 
for this study as well.
For intraoperative measurements, we targeted at different Etsevo. Figure 1 shows the 
overall trend of aepEX and BIS values at different Etsevo. During the emergence period, we 
related the UMSS to the values of both monitors (see Figure 2). Although not significant, 
we observed a slight decrease in the aepEX at the beginning of the emergence period 
compared to the intraoperative values related to Etsevo 1.3% from 55 to 50 units. A 
possible explanation for this unexpected phenomenon could be that the aepEX was also 
influenced by surgical stimuli, despite the local regional technique given. Interestingly, 
the BIS did not show the same behavior.
In conclusion, we have observed that, in children receiving sevoflurane–remifentanil 
anesthesia, the aepEX had a better specificity than the BIS in distinguishing unconscious 
from conscious children at their optimal cutoff values. As the sensitivity and specificity 
vary at different cutoff values, it depends on the chosen cutoff values whether the aepEX 
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should be favored above the BIS. With respect to their ability to distinguish between 
different levels of hypnotic depth, both indices performed equally bad.
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ABSTRACT
BACKGROUND: The aepEXplus monitoring system, which uses mid-latency auditory 
evoked potentials to measure depth of hypnosis, was evaluated in pediatric patients 
receiving desflurane-remifentanil anesthesia.
METHODS: Seventy-five patients, 1–18 years of age (stratified for age; 1–3, 3–6, 6–18 
years, for subgroup analyses), were included in this prospective observational study. The 
aepEX and the bispectral index (BIS) were recorded simultaneously, the latter serving as 
a reference. The ability of the aepEX to detect different levels of consciousness, defined 
according to the University of Michigan Sedation Scale, investigated using prediction 
probability (pk), and receiver operating characteristic (ROC) analysis, served as the primary 
outcome parameter. As a secondary outcome parameter, the relationship between end-
tidal desflurane and the aepEX and BIS values were calculated by fitting in a nonlinear 
regression model.
RESULTS: The pk values for the aepEX and the BIS were, respectively, 0.68 (95% CI, 
0.53–0.82) and 0.85 (95% CI, 0.73–0.96; p=0.02). The aepEX and the BIS had an area under 
the ROC curve of, respectively, 0.89 (95% CI, 0.80–0.95) and 0.76 (95% CI, 0.68–0.84; 
p=0.04). The maximized sensitivity and specificity were, respectively, 81% (95% CI, 
61%–93%) and 86% (95% CI, 74%–94%) for the aepEX at a cutoff value of >52, and 69% 
(95% CI, 56%–81%) and 70% (95% CI, 57%–81%) for the BIS at a cutoff value of >65. The 
age-corrected end-tidal desflurane concentration associated with an index value of 50 
(EC50) was 0.59 minimum alveolar concentration (interquartile range: 0.38–0.85) and 0.58 
minimum alveolar concentration (interquartile range: 0.41–0.70) for, respectively, the 
aepEX and BIS (p=0.69). Age-group analysis showed no evidence of a difference regarding 
the area under the ROC curve or EC50.
CONCLUSIONS: The aepEX can reliably differentiate between a conscious and an 
unconscious state in pediatric patients receiving desflurane-remifentanil anesthesia.
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BACKGROUND
Monitoring the depth of hypnosis (DoH) in anesthetized patients provides the 
anesthesiologist with significant additional information, enabling one to adjust the 
dose of anesthetic agents more adequately, according to the needs of the patient. DoH 
monitoring in children has been shown to result in the use of lower doses of anesthetic 
drugs and a faster recovery [1-3]. Bearing in mind the ongoing discussion about potential 
neurotoxic effects of anesthetic drugs on the developing brain, this technology can help 
prevent anesthetic drug overdosing, adding safety to the conduct of pediatric anesthesia.
Mid-latency auditory evoked potentials (MLAEP) can be utilized to measure the DoH 
during anesthesia [4-7]. The developmental time of MLAEP extends through the first 
decade of life [8], as opposed to the raw electroencephalogram (EEG), which is not mature 
before early adulthood. MLAEP are therefore a potentially more useful parameter to 
assess the DoH than EEG in children.
The aepEXplus monitor (aepEX) is a commercially available DoH monitor that utilizes 
MLAEP. In previous studies, the performance of the aepEX was evaluated in children during 
propofol and sevoflurane anesthesia [9,10]. Desflurane, due to its low blood-gas partition 
coefficient, has a unique pharmacokinetic profile, which, from a clinical perspective, can 
best be described as “fast in-fast out.” Desflurane is a challenging drug for DoH monitors 
because they have to calculate their DoH indices in a clinical setting characterized by fast 
changes in hypnotic drug target concentration.
The current study was conducted to assess the performance of the aepEX monitor in 
children during desfluraneremifentanil anesthesia. For means of reference, bispectral 
index (BIS) values were also recorded simultaneously.
The primary objective of this prospective observational study was to assess the ability of 
the aepEX to detect the return of consciousness during emergence from anesthesia. Our 
secondary objective was to assess the relationship between the aepEX and different end-
tidal desflurane concentrations. 
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METHODS
This article adheres to the applicable STrengthening the Reporting of OBservational 
studies in Epidemiology (STROBE) guideline. The study was reviewed and approved 
on May 12, 2011 by the Institutional Review Board of the Erasmus MC, Rotterdam, the 
Netherlands (MEC 2011–104, NL 35976.078.11) and registered in the Dutch trial register 
before inclusion of the first patient (http://www.trialregister.nl/trialreg/admin/ rctview.
asp?TC=2983, NTR2983, principal investigator: Y. M. Cheung, date of registration: July 
12, 2011). Written informed consent was obtained from the participants’ parents or 
guardians. According to the Dutch law, additional written informed assent was collected 
from children ≥12 years of age.
Patients scheduled in the Erasmus MC, Sophia children’s hospital for elective general, 
urologic, plastic, or orthopedic surgery were eligible for inclusion. The entire cohort of 75 
patients was stratified for age into 3 groups of 25 children each (group 1: 1–3 years; group 
2: 3–6 years; and group 3: 6–18 years) to detect possible age-related effects. Exclusion 
criteria consisted of known allergies to any medication in the study protocol (remifentanil, 
desflurane, sevoflurane, and/or propofol), the presence of a clinically significant hearing 
impairment, the use of medication (eg, premedication, antiepileptics), having a condition 
affecting the EEG (to prevent bias), and a planned postoperative admittance to the 
pediatric intensive care unit.
Conduct of Anesthesia
After arrival at the operating room, an intravenous cannula was inserted and remifentanil 
0.5 µg·kg−1 was administered over 15 seconds followed by a continuous infusion of 
0.1 µg·kg−1·minute−1. General anesthesia was induced with propofol 3.0–5.0 mg·kg−1.
When it was not possible to obtain intravenous access in the awake child, induction 
was performed with sevoflurane by facemask, after which an intravenous access was 
obtained in the anesthetized child. Immediately after an intravenous cannula was in 
place, remifentanil was administered according to the same scheme as in awake children. 
After insertion of a laryngeal mask, airway desflurane was slowly washed in to an end-
tidal desflurane concentration (Etdes) of approximately 1 minimum alveolar concentration 
(MAC), adjusted for age [11].
Once the airway was secured, locoregional analgesia was given whenever possible and 
appropriate. Ropivacaine 0.2% was used for low-volume ultrasound-guided peripheral 
locoregional techniques and caudal blocks. Penile nerve blocks were performed with 
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bupivacaine 0.5%. When locoregional analgesia was not an option, for whatever reason, 
remifentanil was increased to a dose of 0.3–0.4 µg·kg−1·minute−1 during the surgery.
During anesthesia, all patients were monitored with our standard equipment, which 
consists of electrocardiogram, pulse oximetry, noninvasive blood pressure measurement, 
temperature, capnography, and inspired and end-tidal concentrations of oxygen, 
sevoflurane, and desflurane.
aepEX and BIS Monitoring
After induction of general anesthesia, the skin on the forehead was swabbed with alcohol 
and abraded with Sensor Prep (Medical Device Management, Essex, United Kingdom) to 
decrease the impedance to a low enough level to allow for both aepEX and BIS monitoring. 
aepEX and BIS electrodes were then attached, respectively, on the left and right sides of 
the patient’s forehead according to the manufacturer’s recommendation. A commercially 
available over-the-ear headphone (MDR-V150; Sony Europe, London, United Kingdom) 
was connected to the aepEX because standard earplugs are unsuitable for small children. 
aepEX index values were transferred to a personal computer at 5-second intervals using 
the aepEX’s logger software (version 1.3, Medical Device Management, Essex, United 
Kingdom). aepEX data labeled with “artefact,” as shown by the aepEX logger software, 
were excluded from subsequent analysis.
The BIS Vista monitoring system (version 2.02, Aspect Systems International, de Meern, 
the Netherlands) was used, with a smoothing rate of 15 seconds. BIS data were directly 
transferred at 1-second intervals to a USB stick plugged into the monitor. BIS values with 
a signal quality <50%, as indicated by the BIS signal quality index, were excluded from 
subsequent analysis.
Data collection for study purposes started 15 minutes after administration of propofol 
or when the end-tidal sevoflurane concentration, in the case of an inhalation induction, 
was 0% as measured by our anesthesia machine (Primus, Draeger, Lübeck, Germany). 
Patients were primarily allowed to breathe spontaneously during the surgical procedure. 
In case of hypoventilation (end-tidal CO2 >6.0 kPa), mechanical ventilation was used to 
reestablish and maintain normocapnia (end-tidal CO2 of 4.5–6.0 kPa). During the surgical 
procedure, Etdes was initially titrated to 1.5 MAC and decreased every 3 minutes by 1 vol% 
to a minimum of 0.7 MAC, corrected for age. According to Taylor and Lerman [11], we 
defined 1 MAC as 8.7%, 8.6%, 8.0%, and 7.5% for children 1–3, 3–5, 5–12, and ≥12 years of 
age. At the start of wound closure, Etdes was decreased to 0.5 MAC. After completion of the 
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surgical procedure, the administration of desflurane was discontinued, and the fresh-gas 
flow was set to 10 L·minute−1 using 100% oxygen.
During the emergency period, the DoH was assessed according to the University of 
Michigan Sedation Scale (UMSS) [12] until the patient had a UMSS ≤1. The UMSS consists 
of 5 levels, including “awake/alert,” “minimally sedated,” “moderately sedated,” “deeply 
sedated,” and “unarousable,” which correspond, respectively, to a UMSS of 0, 1, 2, 3, and 4.
Data analyses were performed with the average index value over 10 seconds before the 
intended time points as described previously.
Statistical Analysis
Primary Outcome — The relationship between the index values and different DoH (UMSS) 
were analyzed by calculating the prediction probability value (pk), which was described 
by Smith et al. [13] A pk value and the area under the curve (AUC) derived from a receiver 
operating characteristic (ROC) analysis are both measures of the discriminative ability 
of a predictor; to set it more precisely, pk is a generalization of the AUC. ROC analyses 
can only be performed with dichotomous outcome parameters, whereas pk also allows 
assessment of the discriminative power of a predictor when there are >2 states. A pk of 1.0 
corresponds with a DoH monitor that always predicts the correct UMSS. If a DoH monitor 
predicts the correct UMSS in only 50% of the cases, then it will have a pk of .5. A pk<.5 
describes an inverse relationship. An inverse relationship will be expressed as 1 − pk for a 
better understanding. Pk values were only computed when ≥3 different UMSS values were 
observed because computing this for only 2 different values would be the same as a ROC 
with its corresponding AUC. For each individual patient, the pk value would be computed, 
after which the mean pk value for its corresponding age group would be calculated.
ROC analyses and its corresponding AUC were performed to investigate the predictive 
capabilities of the DoH monitor to distinguish consciousness from unconsciousness 
using MedCalc for Windows, version 5.6.1 (MedCalc Software, Mariakerke, Belgium). 
The cutoff index value at which both the sensitivity and the specificity was the highest 
was defined as the maximized combination. For analysis, we defined consciousness and 
unconsciousness as a UMSS of, respectively, ≤1 and ≥2.
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Secondary Outcome — aepEX and BIS data were fitted in a nonlinear regression model to 
analyze the relationship between index values and different Etdes. An inhibitory sigmoid 
Emax model was used for this purpose:
E = E0 +
(Emax – E0)
1 + 10(logEC50–x)y
E0 and Emax are, respectively, the minimum and maximum value of the index values, which 
were 0 and 100. The EC50 is the Etdes at which an index value of 50 was reached on the DoH 
monitors. E is the predicted index value during the administration of an Etdes of x, whereas 
γ is the Hillslope, which was variable to optimize the best fit for this model. The EC50 of 
each individual patient was first computed after which the median of the corresponding 
group was calculated.
Continuous data were tested for normality by visual inspection and the D’Agostino & 
Pearson omnibus normality test. To compare the EC50 between the aepEX and BIS (of the 
cohort and different age groups), the Wilcoxon matched-pairs signed rank test was used. 
When comparing the EC50 among different age groups, a Kruskal-Wallis test was used. 
Pk values of the aepEX and BIS (of the cohort and different age groups) were compared 
with a paired t test, while pk values among different age groups were analyzed with 
an unpaired t test. These tests were computed and analyzed with GraphPad Prism for 
Windows, version 6.04 (GraphPad Software, San Diego, CA). The method of DeLong et 
al. [14] was applied for analysis of the (paired) AUC between the aepEX and BIS monitor. 
The comparison of the AUC of different age groups was made according to the method 
of Hanley and McNeil [15]. All analyses among or within the 3 age groups were corrected 
for multiple testing with the Bonferroni correction, except for the KruskalWallis test, for 
which Dunn’s post hoc analysis was applied.
Descriptive analyses were performed with IBM SPSS Statistics for Windows, version 21.0 
(IBM Corp, Armonk, NY). Variables were presented as mean ± standard deviation unless 
stated otherwise. P-values <.05 were considered statistically significant.
A sample size of 25 children per age group and the defined age groups correspond to 
similar published studies concerning DoH monitors [6,16,17]. Previous studies have 
assumed that a reliable pk value can be computed with a sample size of >20 patients [18-
20].
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RESULTS
Between December 2012 and September 2014, a total of 75 patients were included, of 
whom 7 had to be excluded secondarily due to the following reasons: administration 
of premedication (n=1, group 2), tracheal intubation (n=1, group 1), and ventilation 
difficulties before or during the data collection (n=4, group 1; n=1, group 3). Details 
concerning baseline characteristics of the patient are shown in Table 1.
During the wash-in period of desflurane, 28 patients (n=11, group 1; n=8, group 2; n=9, 
group 3) had difficulties maintaining normocapnia, despite mechanical ventilation. 
In these patients, a further increase of desflurane was avoided, and intraoperative 
measurements were started at an end-tidal desflurane concentration <1.5 MAC. In another 
3 patients (n=1, group 1; n=2, group 2), the target MAC of 1.5 could not be reached due 
to an unexpected short surgical procedure. Furthermore, we were unable to collect data 
until a UMSS of 1 was reached in 3 patients (n=2, group 2; n=1, group 3) due to patient 
agitation during emergence. In 1 patient (group 3), the aepEX could not compute any 
index values due to excessive artifact contamination of the signal. From this patient, only 
BIS values from the emergency period were available for analysis.
Data during emergence were available in 45 patients in which ≥3 UMSS values could be 
observed. The quality of the EEG signal was sufficient to compute 13 pk values for the 
aepEX and 37 for the BIS. A paired t test was possible in 12 pk data pairs, resulting in a pk 
value of 0.68 (95% CI, 0.53–0.82) for the aepEX and 0.85 (95% CI, 0.73–0.96) for the BIS 
(p=0.02). Because only 12 pairs of pk values were available for analysis, a subsequent age-
group analysis was abandoned.
The maximized combination of sensitivity and specificity of the aepEX was 81% (95% CI, 
61%–93%) and 86% (95% CI, 74%–94%) at an index value >52. This was for the BIS at an 
index value of >65, during which the sensitivity was 69% (95% CI, 56%–81%) and the 
specificity 70% (95% CI, 57%–81%). A detailed relationship between index value and 
sensitivity and specificity are plotted in Figures 1 and 2.
Paired comparisons of the AUC of the aepEX and BIS monitor showed no evidence for a 
difference between the entire cohort or the different age groups. Details are shown in 
Table 2. We also found no evidence of a difference when comparing AUCs of the 3 age 
groups with each other after correction for multiple testing.
aepEX in children during desflurane/remifentanil 93
6
100
90
80
70
60
50
40
30
20
10
0
20 30 40 50 60 70 80 90 100
aepEX value
Se
ns
iti
vi
ty
/s
pe
ci
c
ity
 (%
)
Figure 1. aepEXplus monitor’s (aepEX) receiver operating characteristic. Sensitivity (solid red lines) and 
specificity (solid blue lines) at different aepEX cutoff values with their respective 95% CIs (dotted red and 
blue lines).
Table 1. Baseline Characteristics.
Characteristics 1–3 y 
(n=20)
3–6 y 
(n=24)
6–18 y 
(n=24)
Entire Cohort
(n=68)
Female, no. (%) 1 (5) 2 (8) 7 (29) 10 (15)
Age, median [range] (mo) 22 [12–35] 54 [37–70] 139 [73–210] 74 [12–210]
Weight, median (IQR) (kg) 12 (10–15) 17 (15–21) 44 (26–59) 17 (14–26)
Procedure, no. (%)
Upper extremity 3 (15) 3 (13) 5 (21) 11 (16)
Subumbilical 17 (85) 20 (83) 19 (79) 56 (82)
Upper and lower extremity 0 (0) 1 (4) 0 (0) 1 (1)
Locoregional analgesia technique, 
no. (%)
Caudal 17 (85) 16 (67) 9 (38) 42 (62)
Brachial plexus 1 (5) 2 (8) 2 (8) 5 (7)
Lumbosacral plexus 0 (0) 2 (8) 10 (42) 12 (18)
Epidural 0 (0) 1 (4) 0 (0) 1 (1)
None 2 (10) 3 (13) 3 (13) 8 (12)
Abbreviation: IQR, interquartile range.
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A total of 569 aepEX values qualified for subsequent analysis (having no artifacts), while 
the BIS provided 632 index values with a signal quality of >50%. These values are plotted 
in Figure 3, describing the relationship between the index values of both DoH monitors 
during different Etdes and UMSS.
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Figure 2. Bispectral index’s (BIS) receiver operating characteristic. Sensitivity (solid red lines) and 
specificity (solid blue lines) at different BIS cutoff values with their respective 95% CIs (dotted 
red and blue lines).
Table 2. Receiver Operator Characteristics Analysis of the aepEX and BIS Monitor.
Age Group AUC of the aepEX
(Mean: 95% CI)
AUC of the BIS
(Mean: 95% CI)
P-value
Group 1 0.76 (0.55–0.90) 0.63 (0.42–0.81) .31a
Group 2 0.95 (0.79–1.00) 0.84 (0.64–0.95) .05a
Group 3 0.99 (0.85–1.00) 0.98 (0.84–1.00) .87a
Entire cohort 0.89 (0.80–0.95) 0.76 (0.68–0.84) .04
Abbreviations: aepEX, aepEXplus monitor; AUC, area under the curve; BIS, bispectral index; CI, confidence 
interval.
a Uncorrected p-value for multiple testing.
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The age-corrected EC50 for the aepEX (EC50aepEX) was 0.59 MAC (interquartile range: 
0.38–0.85; n=57) and for the BIS (EC50BIS) 0.58 MAC (interquartile range: 0.41–0.70; n=63). 
Eleven EC50aepEX could not be computed due to software limitations (unable to converge 
data; n=2, group 1; n=1, group 2; n=1, group 3), too few intraoperative data (n=1, group  1; 
n=1, group 2; n=1, group 3), and data with too many artifacts (n=3, group 2; n=1, group 3).
Software limitations accounted for 2 missing EC50BIS (n=1, group 1; n=1, group 3) and 3 
for having too few intraoperative data (n=1, group 1; n=1, group 2; n=1, group 3). Both 
monitors had a comparable r2: 0.62 (95% CI, 0.54–0.71) for the aepEX and 0.69 (95% CI, 
0.63–0.76) for the BIS. The Kruskal-Wallis tests comparing the EC50 among different age 
groups also showed no evidence of a difference (p=0.27 for the aepEX and p=0.12 for the 
BIS). Paired comparison (n=57) between the EC50aepEX and EC50BIS resulted in a p-value 
of 0.69. The same comparison for age groups 1, 2, and 3 revealed p-values of, respectively, 
0.38, 0.14, and 0.84.
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Figure 3. Trend of aepEXplus monitor (aepEX) and bispectral index (BIS). Mean index values of 
the aepEX (solid lines) and BIS (dashed lines) with their respective 95% CIs related to different 
end-tidal desflurane concentrations and University of Michigan Sedation Scale (UMSS) values. 
MAC indicates minimum alveolar concentration.
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DISCUSSION
Our study demonstrates that the aepEX monitor differentiates between unconscious and 
conscious pediatric patients with a 10% higher sensitivity and specificity than the BIS 
monitor. As opposed to this finding, the aepEX performs inferiorly to the BIS to correctly 
predict different UMSS. We found no evidence of an age-related difference in performance 
of the aepEX, suggesting that the aepEX performs equally in all patients from 1 to 18 years 
of age.
The results of this study are consistent with our findings from the previous study 
investigating the aepEX in children during propofol and sevoflurane anesthesia [9,10]. This 
finding implies that the aepEX monitor also performs equally during different commonly 
used anesthetics in children, that is, propofol, sevoflurane, and desflurane.
As proposed by Smith et al., [13] the pk approach to measure the performance of an 
anesthetic depth indicator is aimed to include different levels of anesthetic depth in the 
analysis. We could, however, only measure 2 levels of anesthetic depth in the majority of 
our patients, which is probably attributable to the properties of desflurane, for example, 
its low blood-gas partition coefficient. Nonetheless, we found evidence of the superiority 
of the BIS over the aepEX in discriminating different UMSS levels.
The concept that consciousness has levels has been accepted for decades. Many different 
clinical observational scales have been designed, validated, and used to assess the level 
of consciousness, among them the Observer’s Assessment of Alertness/Sedation scale 
and the UMSS. All of these scales assume that DoH is graded and that, beginning with 
a fully awake subject, each step of the scale reflects a “lower level of consciousness,” or, 
in the context of anesthesia research, “depth of hypnosis.” By now we are still not sure 
about the true underlying mechanism(s) of our mental states named consciousness 
and unconsciousness. Regarding unconsciousness, it is even possible that the concept 
of “hypnotic depth” is not correct at all, in other words, that we are either conscious 
or unconscious [21]. Therefore, we also performed an ROC analysis as an alternative 
approach to quantify the monitors’ performance. An ROC analysis requires only 2 
different states (“conscious” and “unconscious”) for analysis. Beside this, it also gives 
a more clinically applicable result, that is, a clear cutoff value with its corresponding 
sensitivity and specificity. In our current study, we found that when choosing the maximal 
sensitivity and specificity, the aepEX is superior to the BIS. Choosing the clinically most 
relevant combination of the sensitivity and specificity of the monitors depends on 
personal preferences regarding the most important monitoring target. When prevention 
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of intraoperative awareness is of paramount importance, a DoH monitor with a higher 
sensitivity is favorable. However, if the sensitivity is chosen too high, the resulting low 
specificity would render the monitor useless (Figures 2 and 3).
By definition, the EC50 is the drug concentration needed to achieve 50% of the drug’s 
maximum effect. In our current study, we fitted our intraoperative data in a nonlinear 
regression model to compute the EC50. However, the EC50 can also be measured by 
recording the end-tidal desflurane concentration while maintaining an index value of 50. 
Fletcher et al. [17] performed such a study by maintaining a BIS of 60 during pediatric 
scoliosis surgery under desflurane anesthesia. The end-tidal concentration desflurane 
needed to maintain a BIS of 60 can be described as an EC60 for the BIS monitor. Although 
an EC60 is different from an EC50 and our study designs are not comparable, we found 
a similar MAC of 0.58. Caution is needed when comparing both studies; despite the 
aforementioned, their EC60 comes close to the EC50BIS we observed.
Although processed EEG and MLAEP have strong relationships with consciousness level, 
we should not solely rely on computed DoH index values. A recent study by Schneider et 
al. [22] supports this concept. They demonstrated that the combination of the BIS monitor 
with other standard monitoring parameters, for example, heart rate and blood pressure, 
resulted in a pk of 1.0 to detect the return of consciousness in adult patients, emphasizing 
the importance of observing the patient as a whole.
Almost all patients in our study received additional locoregional analgesia before the 
surgical procedure, most often a caudal block. Davidson et al. [16] demonstrated that a 
caudal block resulted in a decrease in BIS value of 5 points. The effect of a caudal block on 
the aepEX has not yet been studied. Although remifentanil decreases the MAC of volatile 
anesthetics, the DoH seems to be unaffected by it, which was demonstrated by Schraag et 
al and Guignard et al. [23,24]. Both studies observed no effect of remifentanil on the aepEX 
and BIS index values, and we assume that this also applies for our study.
Other studies have revealed a pk BIS value of .82 and .89, which is similar to our observed 
pk value of .85 [25,26]. However, these results were observed in the adult population 
and concerned pk values detecting different end-tidal desflurane concentrations or eye 
opening after general anesthesia. Because our observed pk BIS value is not comparable to 
other studies and only 13 paired pk values could be computed in our study, interpretations 
of the pk values of the aepEX and BIS are limited.
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The age stratification applied in this study was designed to match similar studies for 
comparison purposes. However, concerns can be made due to the broad range of group 
3 (6–18 years of age). Because the MLAEP is still developing until the first decade of life 
[8], this group consisted of children with developing MLAEP and fully developed MLAEP 
pathways. However, because the development of the MLAEP is a continuous process, we 
would at least expect to find a difference between group 1 (fully undeveloped MLAEP) 
and group 3 (MLAEP in final development combined with fully developed MLAEP) if an 
age-dependent performance for the aepEX exists. It would be interesting to compare 
group 3 with adult data, but unfortunately no such comparable study was published.
Our study population consisted predominantly of male children. However, we believe it is 
unlikely that this factor affected our study.
In conclusion, our current study observed that the aepEX monitor could reliably 
differentiate unconsciousness from consciousness in pediatric patients during 
remifentanil-desflurane anesthesia combined with a locoregional technique.
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Many different scales and measurement methods have been developed to assess the 
anesthetic depth in the past few decades [1]. In general, the depth of anesthesia was 
measured by the response of the patient to a stimulus (tactile/pain or sound). This requires 
the patient to respond physically (movement) or verbally. Verbal response however, is 
not possible when the trachea of the patient is intubated or a laryngeal mask inserted. 
Furthermore, neuromuscular relaxing agents abolish movement of striated muscles and 
analgesics attenuate pain sensation. Without a reliable response from the patient to 
reflect his or her current depth of hypnosis, these scales are difficult if not impossible to 
interpret when balanced anesthesia is applied.
What is the current opinion regarding depth of hypnosis monitoring in 
children?
Depth of hypnosis monitoring devices are expected to be more dependable in these 
situations, since these circumvent the requirement of a (vocal) motor response from the 
patient to a stimulus. Despite the lack of evidence for it, monitoring is traditionally used 
with the intention to prevent intraoperative awareness in children, as was demonstrated 
in our survey amongst ESPA members. 
Despite the fact that there is literature available supporting a faster emergence phase 
when anesthesia was guided by a depth of hypnosis monitor, due to more efficient 
dosing of anesthetics, this was considered a less important reason to use such a monitor 
in children. Avoiding possible side effects of the anesthetic agents by decreasing the dose 
administered, was expected to an important reason to use depth of hypnosis monitoring 
in children, especially considering the current discussion regarding neurotoxicity to the 
developing brain of the child. However, this argument was considered the least important 
according to our the ESPA members as well. 
Our research also revealed that anesthesiologists doubt about whether use of these devices 
can prevent intraoperative awareness in children. This was their main reason not to use it. 
Even ESPA members who did use hypnosis monitoring in children had their reservations 
towards its reliability in younger children and/or the type of anesthetic(s) used. This was 
illustrated by the less frequent use of hypnosis monitoring devices in younger children 
and when anesthesia was maintained by volatile anesthetics. Inadvertently, these two 
items were also ranked as the most important requirements of a hypothetical ideal depth 
of hypnosis monitor to overcome. 
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Besides having doubts towards the reliability of a depth of hypnosis monitor, the lack of 
a consensus in how to interpret its index values also persists according to our survey. The 
thoughts of our respondents however, are mostly based on the BIS monitor, since 77% 
of the “Users” used a BIS monitor to assess the depth of hypnosis in children. This makes 
the results difficult to extrapolate to all depth of hypnosis monitors available. A probable 
downside of using the BIS monitor in children is that the spontaneous EEG, from which 
the BIS monitor computes its index values, matures through middle age [2]. Kanazawa 
et al. demonstrated that young patients (20 to 30 years) had lower BIS values compared 
to middle-aged (31 to 65 years) or elderly (66 to 80 years) patients during 1 minimum 
alveolar concentration (MAC) of sevoflurane and desflurane anesthesia [3]. This might 
suggest that the BIS monitor is less reliable in the youngest of our patients.
What is currently known concerning MLAEP in children during anesthesia?
The MLAEP on the other hand, matures earlier in life [4]. Reviewing the available literature 
concerning MLAEP monitoring peri-operatively yielded only 15 studies who met our 
lenient inclusion criteria, including a few from our own research group. Except for the 
studies from this thesis, all of them were conducted with MLAEP based monitors which 
are no longer commercially available or were experimental setups. In accordance with the 
adult population, the overall MLAEP waveform of children showed increasing latencies 
and decreasing amplitudes with increasing anesthetics given [5-8]. Also, its performance 
to detect different states of consciousness seems to be reasonable in children [9-
15]. Whether a MLAEP based hypnosis monitor will decrease the rate of unintentional 
intraoperative awareness has not been studied.
Published studies investigating the effect of depth of hypnosis monitoring on 
unintentional perioperative awareness show conflicting results and are conducted in 
the adult population [16,17]. The incidence of unintentional intraoperative awareness 
in children is estimated to be 0.74%, which is much higher compared to adults having 
an incidence of 0.1 to 0.2% [17,18]. However, Blusse van Oud-Alblas et al. reported that 
the children who experienced true awareness in their study (n=6) did not seem to be 
traumatized [19], but taking into account that 50% of the patients develop long-term 
psychological effects after enduring accidental awareness, a reliable depth of hypnosis 
monitor (even for children) seems still to be needed [18]. 
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Figure 1. Median and interquartile range of aepEX values during different UMSS values.
How does a MLAEP monitor perform in children during anesthesia?
In this thesis we evaluated the performance of the aepEX monitor, currently the only 
commercially available MLAEP based depth of hypnosis monitor, in measuring the depth 
of hypnosis during anesthesia in children. Using the BIS monitor as a reference, the aepEX 
seems to perform worse in differentiating different UMSS levels (prediction probability 
values) during propofol, sevoflurane and desflurane anesthesia. However, detecting 
the conscious (UMSS ≤1) and unconscious (UMSS >1) states by the aepEX monitor was 
superior to the BIS monitor during desflurane anesthesia, while being comparable with 
each other during propofol and sevoflurane anesthesia.
When aepEX values against different UMSS scores were plotted in a graph, a sudden sharp 
increase was consistently observed during different kinds of anesthetics when an UMSS 
of 1 was reached (Figure 1).
On the other hand, the BIS monitor showed a more gradual increase over the different 
UMSS values (Figure 2). When compared to the BIS values, the sudden increase in median 
aepEX values resulted in a greater difference between values during an UMSS >1 and 
UMSS of 1. This relationship between the different levels of consciousness and aepEX 
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index values could make its interpretation in clinical practice less ambiguous for the 
assessment of the depth of hypnosis in children.
Subgroup analysis showed comparable results for the different age groups for both 
monitors, indicating that both monitors were just as reliable for the different age groups. 
However, a recent study by Scuisco et al. found higher mean BIS index values for toddlers 
aging 13 months to 36 months compared to infants (1 month to 12 months) or children 
(37 months to 144 months) [20]. The study investigated the effect of age on BIS, response 
entropy and state entropy indexes. Anesthesia was given with sevoflurane. However, 
the dose of sevoflurane was “adjusted in response to clinical signs” and no reproducible 
protocol was described. This could probably explain our different findings concerning the 
effect of age on the BIS index values.
There seems to be a lower correlation between the aepEX values and dose of anesthetics 
administered compared to the BIS values. Both show a negative correlation but, the 
aepEX values were less linear with the concentration anesthetics administered. However, 
the clinical relevance to predict the correct concentration of anesthetic administered is 
questionable for a depth of hypnosis monitor. This is especially true during administration 
of volatile anesthetics, during which the end-tidal concentration is measured by any 
standard modern-day anesthesia machine. For volatile anesthetics the administered 
dose is generally guided by its minimum alveolar concentration (MAC) value. The MAC 
is defined as the concentration vapor needed within the alveoli during which 50% of the 
patients do not move in response to a surgical stimulus. While the absence of movement 
despite a significant stimulus, i.e. surgical stimulus, indicates an adequate depth of 
hypnosis for surgery (comparable to an UMSS of 4), 1 MAC value describes that only 50% 
of the patients has reached this level of depth. Therefore, believing that the MAC is a 
measure of depth of hypnosis for the individual patient is a misconception. 
This thesis has described the thoughts, opinions and (mis)understandings of 
anesthesiologists about the use of depth of hypnosis monitoring in children during 
anesthesia. We described the performance of the aepEX monitor during anesthesia in 
children, demonstrating that it has a reasonable accuracy to detect consciousness from 
unconsciousness and that it is feasible for different age groups. 
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Figure 2. Median and interquartile range of BIS values during different UMSS values.
FUTURE PERSPECTIVES
A few questions remain after this thesis. Anesthesia is not administered in a uniform 
method and different combinations of anesthetics and analgesics (systemic or 
locoregional) are used. The effect of combining anesthetics on a MLEAP based hypnosis 
monitor still remains to be answered. Also, its value in prevention of unintentional intra-
operative awareness in children remains to be elucidated.
As the aepEX index monitor can detect the return of consciousness no more than only 
reasonably, it is not the ideal depth of hypnosis monitor in children. Further investigation 
searching for an even more reliable monitor continues, and the answer might still 
be found in the spontaneous EEG. Density spectral array (DSA) is a method to display 
the spontaneous EEG in a graph by color-coding the intensity of different brainwave 
frequencies, i.e. gamma, beta, alpha, theta, delta and slow waves [21]. Compared to EEG 
based hypnosis monitors, the EEG in a DSA is less processed by a computer algorithm and 
therefor the interpretation depends less on what the algorithm computes, i.e. index value. 
Understanding the EEG and the effect of different anesthetics on it, might help to assess 
the state of the brain more accurately and therefore improving anesthesia technique. 
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However, this means anesthesiologists need to have appropriate knowledge concerning 
EEG recordings and its interpretation, just like capnography, plethysmography, and 
electrocardiography. The brain remains to be one of the most important target organs in 
anesthesia. Since this detailed knowledge about the unprocessed EEG is at present not 
a part of the general skill set of anesthesiologists, we should consider to add this to the 
curriculum of anesthesiology training programs.
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Summary
Chapter 1 explains the concerns about unintentional awareness during anesthesia and 
the potential role for a depth of hypnosis monitor to prevent this. The concerns regarding 
neurotoxicity in children receiving anesthesia, as shown in animal studies, might also 
be averted by a reliable hypnosis monitor. Different variables of the brain can be used 
to assess the depth of hypnosis (DoH), from which the electroencephalogram (EEG) is 
the most commonly used. An alternative could be the mid-latency auditory evoked 
potentials (MLAEP), which could have an advantage in children since it matures earlier in 
life compared to the EEG.
In chapter 2 we assessed the thoughts of practicing anesthesiologists about the use of 
depth of hypnosis monitors in children. We developed an online survey and invited the 
members of the European Society for Paediatric Anaesthesiology to participate in this 
survey to share their thoughts regarding the use, applicability and reliability of hypnosis 
monitoring in children. The survey achieved a response rate of 30% (n=168) and a total of 
138 completed surveys were included for further analysis. Sixty-eight respondents used 
hypnosis monitoring in children (users) and 70 did not (non-users). Sixty-five percent of 
the users reported that prevention of intra-operative awareness was their main reason 
to apply hypnosis monitoring. Among the non-users, the most frequently given reason 
(43%) not to use hypnosis monitoring in children was the perceived lack of reliability 
of the devices used in children. Hypnosis monitoring is used with a higher frequency 
during propofol anesthesia than during inhalation anesthesia. Hypnosis monitoring 
is furthermore used more frequently in children >4 years than in younger children. An 
ideal hypnosis monitor should be reliable for all age groups and any (combination of ) 
anesthetic drug. We found no agreement in the interpretation of monitor index values and 
subsequent anesthetic interventions following from it. We concluded that the prevention 
of intraoperative awareness appears to be the most important reason to use hypnosis 
monitoring in children and the perceived lack of reliability of hypnosis monitoring in 
children is the most important reasons not to use it. No consensus currently exists on how 
to adjust anesthesia according to hypnosis monitor index values in children.
The brain is considered as the major target organ of anesthetic agents. Despite that, 
a reliable means to monitor its function during anesthesia is lacking. Several depth of 
hypnosis monitoring devices are available and most of them are EEG derived. In children 
the EEG develops until adulthood, while MLAEP, which are known to be sensitive to 
anesthetic agents, mature during the first decade of life. MLAEP might therefore be a 
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more reliable parameter to measure the state of the brain during anesthesia in pediatric 
patients. The literature concerning MLAEP based hypnosis monitoring during anesthesia 
in children are set out in chapter 3. This chapter reviews the current literature and 
demonstrates that MLAEP analysis is a reasonable method to assess the depth of hypnosis 
in children during anesthesia. Furthermore, its reliability does not depend on the age of 
the child and the type of commonly used anesthetics. 
The aepEX Plus monitor (aepEX) utilizes the mid-latency auditory evoked potentials and is 
currently the only commercially available MLAEP based hypnosis monitor. In chapter 4 the 
performance of the aepEX as a depth of hypnosis monitor for pediatric patients receiving 
propofol-remifentanil anesthesia was evaluated. aepEX and BIS values were recorded 
simultaneously during surgery in three groups of 25 children (aged 1 to 3, 3 to 6 and 6 
to 16 years). Propofol was administered by target-controlled infusion. The University of 
Michigan Sedation Scale (UMSS) was used to clinically assess the DoH during emergence. 
Prediction probability (pk) and receiver operating characteristics (ROC) analyses were 
performed to assess the accuracy of both DoH monitors. Nonlinear regression analysis 
was used to describe the dose-response relationships for the aepEX, the BIS, and propofol 
plasma concentrations (Cp). The study revealed a pk of 0.36 and 0.21 for the aepEX and 
BIS, respectively (p=0.010). ROC analysis showed an area under the curve of 0.77 and 
0.81 for the aepEX and BIS, respectively (p=0.644). At half-maximal effect (EC50), Cp of 
3.13 µg·mL-1 and 3.06 µg·mL-1 were observed for the aepEX and BIS, respectively. The r2 for 
the aepEX and BIS was 0.53 and 0.82, respectively. Therefore, the aepEX seems to perform 
comparable to the BIS in differentiating between conscious and unconscious states, while 
performing inferior to the BIS in terms of distinguishing different levels of sedation. It also 
does not correlate well with the Cp in children receiving propofol-remifentanil anesthesia.
In Chapter 5 we have evaluated the aepEX as a measure of DoH in children receiving 
sevoﬂurane-remifentanil anesthesia. aepEX and BIS were recorded simultaneously in 75 
children, (1 to 3, 3 to 6, and 6 to 18 years), receiving sevoﬂurane at end-tidal concentrations 
(Etsevo) between 1.5 and 0.5 MAC. The Etsevo at which the aepEX and BIS had a value of 50 
(EC50aepEX and EC50BIS) was calculated by nonlinear regression analysis. The accuracy 
of aepEX and BIS to predict the DoH was assessed by pk and ROC analysis. Seventy-four 
children were included for analysis. The EC50aepEX (2.68%) and EC50BIS (2.10%) were 
comparable; the same accounts for the EC50aepEX of the different age groups and the 
EC50aepEX and EC50BIS of corresponding age groups. The EC50BIS in children aged 1 to 
3 years was lower than in the older age groups (p<0.05). Pk values of the aepEX (0.32, 
CI 95% 0.08–0.56) and BIS (0.47, CI 95% 0.19–0.75) were comparable. The area under 
the ROC curve was 0.72 (CI 95%: 0.62–0.82) and 0.67 (CI 95%: 0.56– 0.77) for the aepEX 
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and BIS, respectively (p=0.54). Optimal cut-off index values were >60 (aepEX) and >68 
(BIS), with corresponding speciﬁcities of 91%, CI 95%: 80–97% (aepEX) and 66%, CI 95%: 
52–77% (BIS). In this study with children receiving sevoﬂurane anesthesia, the aepEX 
outperformed the BIS in distinguishing unconsciousness from consciousness. Both 
indices performed equally badly in differentiating different levels of DoH.
The performance of the aepEX monitor is again evaluated in chapter 6. Only this time in 
pediatric patients during desflurane-remifentanil anesthesia. Seventy-five patients, 1 to 
18 years of age (stratified for age; 1 to 3, 3 to 6, 6 to 18 years, for subgroup analyses), were 
included in this prospective observational study. The aepEX and the BIS were recorded 
simultaneously, the latter serving as a reference. The ability of the aepEX to detect different 
levels of consciousness, defined according to the University of Michigan Sedation Scale, 
was investigated using pk, and ROC analysis, served as the primary outcome parameter. 
As a secondary outcome parameter, the relationship between end-tidal desflurane and 
the aepEX and BIS values were calculated by fitting in a nonlinear regression model. The 
pk values for the aepEX and the BIS were, respectively, 0.68 (95% CI: 0.53–0.82) and 0.85 
(95% CI: 0.73–0.96; p=0.02). The aepEX and the BIS had an area under the ROC curve of, 
respectively, 0.89 (95% CI: 0.80–0.95) and 0.76 (95% CI, 0.68–0.84; p=0.04). The maximized 
sensitivity and specificity were, respectively, 81% (95% CI: 61%–93%) and 86% (95% 
CI: 74%–94%) for the aepEX at a cut-off value of >52, and 69% (95% CI: 56%–81%) and 
70% (95% CI: 57%–81%) for the BIS at a cut-off value of >65. The age-corrected end-tidal 
desflurane concentration associated with an index value of 50 was 0.59 MAC (interquartile 
range: 0.38 to 0.85) and 0.58 MAC (interquartile range: 0.41 to 0.70) for, respectively, the 
aepEX and BIS (p=0.69). Age-group analysis showed no evidence of a difference regarding 
the area under the ROC curve or EC50. The aepEX appears to reliably differentiate between 
a conscious and an unconscious state in pediatric patients receiving desflurane-
remifentanil anesthesia.
Our findings in this thesis are discussed and put in perspective in chapter 7. There 
seems to be a need for a reliable depth of hypnosis monitoring in children and the most 
commonly used hypnosis monitors are lacking in this as perceived by a large portion 
of anesthesiologists participated in our survey. There is also a lack of consensus in how 
to use and interpret these devices during anesthesia in children. While the literature 
demonstrated that the use of MLAEP as a variable to assess the DoH seemed promising, 
the currently only commercially available MLAEP based DoH monitor appears to be only 
reasonably reliable in distinguishing between the conscious and unconscious states in 
children during different anesthesia. Future research concerning DoH monitoring might 
want to focus on less processed EEG, letting the anesthesiologist him-/herself interpreting 
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the state of the brain during anesthesia, while preventing confounded computer 
algorithms. Anesthesiologists should therefore consider to revise their training program 
by implementing teaching about the unprocessed EEG during anesthesia.
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Samenvatting
Hoofdstuk 1 bespreekt de problemen rondom onbedoelde wakkere patiënten tijdens de 
anesthesie en de potentiele rol van een hypnose diepte monitor om dit te voorkomen. De 
zorgen over neurotoxiciteit bij kinderen die onder narcose gaan, waarvoor aanwijzingen 
zijn in dierenstudies, zou mogelijk voorkomen kunnen worden door een betrouwbare 
hypnose diepte monitor. Verschillende variabelen van het brein kunnen worden gebruikt 
om de diepte van hypnose te meten, waarvan het elektro-encefalogram (EEG) het 
meest gebruikt wordt. Een alternatief hiervoor zouden de mid-latency auditory evoked 
potentials (MLAEP) kunnen zijn. Deze zijn mogelijk betrouwbaarder bij kinderen, omdat 
ze eerder volledig ontwikkeld zijn dan het EEG.
In hoofdstuk 2 evalueren wij de gedachten van praktiserende anesthesiologen over 
het gebruik van hypnose diepte monitoring bij kinderen. De leden van de European 
Society for Paediatric Anaesthesiology waren uitgenodigd om een door ons ontworpen 
online enquête in te vullen, zodat zij hun ideeën over het gebruik, toepasbaarheid en 
betrouwbaarheid van hypnose diepte monitoring bij kinderen met ons te delen. De 
enquête werd ingevuld door 30% (n=168) van de respondenten, waarvan er in totaal 
138 enquêtes volledig waren ingevuld en werden gebruikt voor verdere analyse. Acht-
en-zestig respondenten gebruikten hypnose diepte monitoren bij kinderen (users) en 70 
gebruikte dit niet bij kinderen (non-users). Vijf-en-zestig procent van de users meldden 
dat het voorkomen van onbedoelde intra-operatieve bewustzijn hun belangrijkste reden 
was om een dergelijke monitor toe te passen. Onder de non-users was hun beleving van 
de slechte betrouwbaarheid van een hypnose diepte monitor de meest gegeven reden 
(43%) om deze niet te gebruiken bij kinderen. Hypnose monitoren werden vaker ingezet 
tijdens anesthesie met propofol dan met dampvormige anesthetica. Verder werden 
hypnose monitoren vaker gebruikt bij kinderen >4 jaar dan jongere kinderen. Er werd 
geen consensus gevonden over hoe men een hypnose monitor dient te interpreteren en 
eventueel hoe hierop te reageren. We concluderen dat het voorkomen van onbedoelde 
intra-operatieve bewustzijn de meest belangrijke reden blijkt te zijn om een hypnose 
diepte monitor te gebruiken en dat juist het gevoel van gebrek aan betrouwbaarheid van 
een hypnose diepte monitor bij kinderen de meest belangrijke reden is om deze niet te 
gebruiken. Er is op dit moment geen consensus over hoe de anesthesie aan te passen op 
basis van een hypnose monitor index waarden bij kinderen.
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Het brein wordt gezien als een van de belangrijkste doelorgaan voor de anesthetica. 
Desondanks dat ontbreekt er een betrouwbare methode om de functie van dit orgaan te 
monitoren tijdens de anesthesie. Een aantal hypnose diepte monitoren zijn beschikbaar 
en de meerderheid ervan gebruikt het EEG hiervoor. Bij kinderen ontwikkelt het EEG 
verder tot en met in de volwassenheid, terwijl het MLAEP, waarvan bekend is dat het 
gevoelig is voor anesthetica, volledig ontwikkeld is gedurende de eerste 10 levensjaren. 
Daardoor zou het MLAEP mogelijk een betrouwbaardere variabele kunnen zijn om de 
status van het brein te meten tijdens anesthesie bij kinderen. De beschikbare literatuur 
over MLAEP gebaseerde hypnose diepte monitoring tijdens anesthesie bij kinderen 
worden uiteengezet in hoofdstuk 3. Dit hoofdstuk beoordeelt de huidige literatuur en laat 
zien dat MLAEP-analyse een redelijke methode is om de diepte van hypnose bij kinderen 
tijdens anesthesie te meten. Verder lijkt de betrouwbaarheid ervan niet afhankelijk te zijn 
van de leeftijd en de verschillende veelgebruikte anesthetica.
De aepEX Plus monitor (aepEX) gebruikt mid-latency auditory evoked potentials en is 
op dit moment de enige commercieel beschikbare MLAEP gebaseerde hypnose diepte 
monitor. In hoofdstuk 4 wordt de prestatie van de aepEX als hypnose diepte monitor 
geëvalueerd bij kinderen die propofol-remifentanil anesthesie krijgen. aepEX en BIS 
waarden werden simultaan opgeslagen tijdens de operatie van drie groepen van 25 
kinderen (leeftijd 1 tot 3, 3 tot 6 en 6 tot 16 jaar). Propofol werd toegediend middels target-
controlled infusion. De University of Michigan Sedation Scale (UMSS) werd gebruikt om 
de klinische diepte van hypnose te objectiveren gedurende de uitleiding van de narcose. 
Prediction probability (pk) en receiver operating characteristics (ROC) analyses werden 
gebruikt om de nauwkeurigheid van beide monitors te evalueren. 
Non-lineaire regressieanalyse werd gebruikt om de relatie tussen de plasmaconcentratie 
propofol (Cp) en het effect op de aepEX en BIS monitor te beschrijven. Het onderzoek 
toont een pk van 0.36 en 0.21 voor respectievelijk de aepEX en BIS monitor (p=0.010). ROC 
analyse laat een oppervlakte onder de curve zien van 0.77 en 0.81 voor respectievelijk 
de aepEX en BIS (p=0.644). Op de helft van het maximale effect (EC50), was de Cp voor de 
aepEX en BIS respectievelijk 3.13 µg·mL-1 en 3.06 µg·mL-1. De r2 voor de aepEX en BIS waren 
respectievelijk 0.53 en 0.82. Hieruit lijkt de aepEX vergelijkbaar te presteren met de BIS 
monitor in het differentiëren tussen “wakkere” en “slapende” patiënt, terwijl het slechter 
presteert in het onderscheiden van verschillende niveaus van sedatie ten opzichte van 
de BIS. De aepEX correleert ook matig met de Cp in kinderen onder propofol-remifentanil 
anesthesie. 
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In hoofdstuk 5 hebben wij de aepEX geëvalueerd als een maat voor de diepte van 
hypnose bij kinderen die sevofluraan-remifentanil anesthesie kregen. aepEX en BIS 
waarden werden simultaan verzameld van 75 kinderen (1 tot 3, 3 tot 6 en 6 tot 18 jaar), 
die een endtidal sevofluraan (Etsevo) concentratie kregen tussen 1,5 en 0,5 MAC. De Etsevo 
waarop de aepEX en BIS waarde 50 was (EC50aepEX en EC50BIS) werd berekend middels 
non-lineaire regressieanalyse. De betrouwbaarheid van de aepEX en BIS om de diepte 
van hypnose te voorspellen werd beoordeeld met pk en ROC analyse. Vier-en-zeventig 
kinderen waren geïncludeerd voor analyse. De EC50aepEX (2.68%) en EC50BIS (2.10%) waren 
vergelijkbaar; hetzelfde gold voor de EC50aepEX van de verschillende leeftijdsgroepen 
en tussen de EC50aepEX en EC50BIS van dezelfde leeftijdsgroepen. De EC50BIS was lager 
voor de kinderen van 1 tot 3 jaar vergeleken met de oudere leeftijdsgroepen (p<0.05). 
Pk waarden voor de aepEX (0.32, CI 95% 0.08–0.56) en BIS (0.47, CI 95% 0.19–0.75) 
waren vergelijkbaar. De oppervlakte onder de ROC curve waren respectievelijk 0.72 (CI 
95%: 0.62–0.82) en 0.67 (CI 95%: 0.56–0.77) voor de aepEX en BIS (p=0.54). De optimale 
afkap punten voor de index waarden waren >60 (aepEX) en >68 (BIS), met daarbij de 
corresponderende specificiteit van 91%, CI 95%: 80–97% (aepEX) en 66%, CI 95%: 52–
77% (BIS). In dit onderzoek met kinderen die sevofluraan-remifentanil anesthesie kregen, 
overtrof de aepEX de BIS monitor in het onderscheiden van bewusteloze en bewuste 
patiënten. Beide monitoren presteren even slecht in het differentiëren van verschillende 
niveaus van hypnose diepte.
De prestaties van de aepEX monitor wordt opnieuw geëvalueerd in hoofdstuk 6. Dit keer 
bij pediatrische patiënten die desfluraan-remifentanil anesthesie ondergaan. Vijf-en-
zeventig patiënten, van 1 tot 18 jaar (gestratificeerd op leeftijden, 1 tot 3, 3 tot 6 en 6 tot 
18 jaar, voor subgroep analyse), werden geïncludeerd in dit prospectief observationeel 
onderzoek. De aepEX en BIS waarden werden simultaan verzameld, waarvoor de BIS 
als referentie werd gebruikt. Het vermogen van de aepEX om verschillende niveaus 
van hypnose diepte te meten, gedefinieerd volgens de University of Michigan Sedation 
Scale, werd onderzocht door middel van pk en ROC analyse en diende als de primaire 
uitkomst maat. Als secundaire uitkomst maat werd de relatie tussen endtidal desfluraan 
en de aepEX en BIS waarden gebruikt, welke berekend werd door middel van non-lineaire 
regressieanalyse. De pk waarden van de aepEX en BIS waren respectievelijk 0.68 (95% CI: 
0.53–0.82) en 0.85 (95% CI: 0.73–0.96; p=0.02). De aepEX en BIS hadden een oppervlakte 
onder de ROC curve van respectievelijk, 0.89 (95% CI: 0.80–0.95) en 0.76 (95% CI, 0.68–0.84; 
p=0.04). De maximale combinatie van sensitiviteit en specificiteit waren respectievelijk 
81% (95% CI: 61%–93%) en 86% (95% CI: 74%–94%) voor de aepEX met een afkapwaarde 
van >52, en 69% (95% CI: 56%–81%) en 70% (95% CI: 57%–81%) voor de BIS met een 
afkapwaarden van >65. De endtidal desfluraan concentratie (gecorrigeerd voor leeftijd) 
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waarbij de index waarde 50 was, was voor de aepEX 0.59 MAC (interkwartielafstand: 0.38 
tot 0.85) en voor de BIS 0.58 MAC (interkwartielafstand: 0.41 tot 0.70; p=0.69). Analyse 
van de verschillende leeftijdsgroepen laat geen verschil zien voor de oppervlakte onder 
de ROC curve en EC50. De aepEX lijkt betrouwbaar te differentiëren tussen bewust en 
bewusteloosheid bij pediatrische patiënten die desfluraan-remifentanil anesthesie 
krijgen.
Onze bevindingen van dit proefschrift worden besproken en in perspectief gebracht in 
hoofdstuk 7. Er lijkt vraag te zijn voor een betrouwbare hypnose diepte monitor voor 
kinderen, wat volgens een groot deel van de anesthesiologen, die deel hadden genomen 
in onze enquête, ontbreekt bij de gangbare hypnose diepte monitoren. Er ontbreekt ook 
een consensus over hoe een hypnose diepte monitor gebruikt dient te worden en hoe 
deze geïnterpreteerd moet worden bij kinderen tijdens anesthesie. Hoewel de literatuur 
laat zien dat MLAEP een veel belovende variabele is om de diepte van hypnose te meten, 
lijkt de op dit moment enige commercieel beschikbare MLAEP gebaseerde hypnose diepte 
monitor slechts maar redelijk te kunnen differentiëren tussen bewuste en bewusteloze 
pediatrische patiënten tijdens anesthesie met verschillende anesthetica. Toekomstige 
onderzoeken op het gebied van hypnose diepte monitoring zouden zich mogelijk 
moeten concentreren op minder bewerkte EEG, zodat de anesthesioloog zelf de conditie 
van het brein kan beoordelen tijdens de anesthesie zonder dat deze beïnvloed wordt 
door een computer algoritme. Anesthesiologen zouden daarom moeten overwegen om 
het curriculum uit te breiden met kennis over het onbewerkte EEG tijdens anesthesie.
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